Category: Prescriptions for Policy

[Forum] [Spotlight] [Commentary] [Research] [Events] [News]

• The Medicare Modernization Act 2003 Mark McClellan, July 2004
• Questioning the Evidence in Evidence-Based Guidelines Michael Weber, M.D., July 2004
• Our competitors understand why America is the global leader in biotechnology. Robert Goldberg, Ph.D., April 2005
• Profits and Progress Cannot Be Separated Robert Goldberg, Ph.D., August 2004
• The Stem-Cell Wars Robert Goldberg, Ph.D., August 2004
• Me-too Mythology Robert Goldberg, Ph.D., August 2004
• Prescription Against Medical Terror Robert Goldberg, Ph.D., August 2004
• Britain's National Health Service Embraces a New Faith in Market Incentives Benedict Irvine, September 2004
• European Price Controls Harm Patient Health Robert Goldberg, Ph.D., September 2004
• KerryCare for the Greatest Generation? Robert Goldberg, Ph.D., September 2004
• Does Importation Save Money and Lives? Not in Europe. Robert Goldberg, Ph.D., September 2004
• The rush to black label (or blackball) SSRIs. Sally Satel, MD, September 2004
• Waiting for the 17th plan Jacob Arfwedson, October 2004
• Fantasy’s End. Sally C. Pipes, December 2004
• Christopher Reeve: Action Hero Robert Goldberg, Ph.D., October 2004
• Blame Congress Robert Goldberg, Ph.D., October 2004
• Small Businesses are Saving Money and Insuring More People Today With Health Savings Accounts Newt Gingrich, , Vince Haley, November 2004
• Figuring the Benefits and Risks of Drug Therapy Michael Weber, M.D., November 2004
• Mr. President, stay the course. Robert Goldberg, Ph.D., November 2004
• Don’t Kill The Pharmaceutical Golden Goose Gilbert L. Ross, M.D., November 2004
• Vioxx Backlash Could Derail Future of Medicine Robert Goldberg, Ph.D., , Paul Howard, Ph.D., January 2005
• Innovative approaches to relief Robert Goldberg, Ph.D., January 2005
• A limited solution for a limited problem. Sally C. Pipes, February 2005
• The New Frontier for Drug Safety Gualberto Ruańo, M.D., Ph.D., , Robert Goldberg, Ph.D., February 2005
• Can Free Market Principles Work With Pharmaceutical Price Controls? Benjamin Zycher, Ph.D., March 2005
• The War on Carcinogens vs. The War on Cancer Elizabeth Whelan, March 2005
• The Cost of Germs Betsy McCaughey, March 2005
• Congress is stalling real Medicaid reform. David Gratzer, April 2005
• Death and Taxes. Roger Bate, May 2005
• Faster Cures For the Future Robert Goldberg, Ph.D., May 2005
• The Return of HillaryCare David Gratzer, May 2005
• Cancer patients are paying for the FDA's caution. Dr. Scott Gottlieb, May 2005
• The Vioxx Panic Marc Siegel, MD, June 2005
• Hotel California Health Care Sally C. Pipes, July 2005
• In Pursuit of Fewer Medicines and More Lawsuits Benjamin Zycher, Ph.D., July 2005
• Doctor, spare me the politics - you're making me sick Philip Stevens, August 2005
• Focusing the spotlight on the real Scott Gottlieb Robert Goldberg, Ph.D., September 2005
• New FDA leadership Robert Goldberg, Ph.D., October 2005
• Bare-Knuckle Politics Leads to Bad Public Policy Peter J. Pitts, October 2005
• The Lion and the Lambs Laying Down Together Benjamin Zycher, Ph.D., October 2005
• Head-to-Head Drug Trials at California's Ballot Box John R. Graham, November 2005
• The Acute Nature of Chronic Problems Peter J. Pitts, November 2005
• A Victim of Their Own Devices Peter J. Pitts, December 2005
• Ghostwriters go bump in the medical journals. Peter J. Pitts, December 2005
• Ariel Sharon and Stroke Treatment Marc Siegel, MD, January 2006
• Suicide Risks and SSRIs: New Data Should Change the Equation Sally Satel, MD, January 2006
• Smoking Out Cliches About Race Sally Satel, MD, February 2006
• The Pain Medicines: Another Chapter is Written Michael Weber, M.D., January 2006
• Policy Forum: The State of the Union Health Care Proposals Joseph R. Antos, Ph.D., February 2006
• Policy Forum: The State of the Union Health Care Proposals Benjamin Zycher, Ph.D., February 2006
• Policy Forum: The State of the Union Health Care Proposals James R. Copland, February 2006
• Policy Forum: The State of the Union Health Care Proposals Paul Howard, Ph.D., February 2006
• Reality-driven Health-care Reform Cynthia Ramsay, February 2006
• California’s Uninsured: Not as bad a problem as you might think. John R. Graham, March 2006
• Where Good and Bad Drugs Mix Katherine Eban, March 2006
• Counterfeit drugs: getting to the root of the problem Philip Stevens, March 2006
• Good News on Evista Comes Too Late for Some Gilbert L. Ross, M.D., April 2006
• They'd Sooner Fix Medicaid Regina E. Herzlinger, , Tom Coburn, May 2006
• Where Would You Rather Be Sick? David Gratzer, June 2006
• How Safe and Effective is the FDA? Richard A. Epstein, June 2006
• The Cost of a Caring Leviathan: The FDA at 100 John R. Graham, July 2006
• A Tale of Two Anniversaries David Gratzer, July 2006
• The FDA at 100 Henry I. Miller, July 2006
• The Bureaucratization of Safety and Effectiveness Benjamin Zycher, Ph.D., July 2006
• How Depressed are U.S. Drug Consumers? John Vernon, , Rexford Santerre, September 2006
• For Health Care Woes, a Capitalism Prescription David Gratzer, October 2006
• RX for New York's Ailing Health Care David Gratzer, November 2006
• A Tale Of Two Drug Classes Shows Why U.S. Mustn't Go Europe's Way Paul Howard, Ph.D., December 2006
• We oppose negotiations on Medicare Part D drug prices Benjamin Zycher, Ph.D., January 2007
• Where Has Bird Flu Flown? Marc Siegel, MD, February 2007
• Pharmaceutical Importation, Price Controls, Federal Price Negotiations, and the Interests of Consumers
• Who Killed U.S. Medicine? Regina E. Herzlinger, July 2007
• Congress Is Full of SCHIP Paul Howard, Ph.D., July 2007
• CAMBRIDGE V CHICAGO:
  AN ANSWER TO DR. ARNOLD RELMAN’S NEW REPUBLIC REVIEW OF OVERDOSE Richard A. Epstein, August 2007
• Bush right to curb insurance 'crowd out' Tarren Bragdon, September 2007
• An Information Prescription for Drug Regulation Joseph Bernstein, MD, FACS, , Anita Bernstein, JD, August 2007
• HILLARYCARE'S 'GROUNDHOG DAY' Paul Howard, Ph.D., September 2007
• To Save Cancer Patients in the UK, the NHS Needs a Dose of Competition Andrew Haldenby, November 2007
• Rudy Is Right In Data Duel About Cancer David Gratzer, November 2007
• The free lunch never dies Benjamin Zycher, Ph.D., November 2007
• Foreign Health Affairs Regina E. Herzlinger, November 2007
• The Health Of Nations Paul Howard, Ph.D., December 2007
• A 'cure' worse than gangrene Paul Howard, , James R. Copland, March 2009
• Best Practices for Health Care (and Tort) Reform Joseph Bernstein, MD, MS and Duncan MacCourt, MD, JD, August 2009

• Lynch 'Em Forbes, 6-18-07
• Science is not a democracy by Gilbert L. Ross, M.D., Washington Times, 6-15-07
• Avandia-type crisis could hit other drugs Reuters News, 6-4-07
• Balancing Medical Risks; The FDA needs more authority to monitor drugs following their approval Washington Post, 6-4-07
• At risk: vaccines by Paul A. Offit, The Boston Globe, 6-3-07
• Glaxo Letter Defends Avandia Wall Street Journal, 5-31-07
• The Obama Health Plan by Atul Gawande, The New York Times, 5-31-07
• Evolving Beyond Traditional Employer-Sponsored Health Insurance by Stuart Butler, Brookings Institution, 5-31-07
• Journalistic Malpractice by Dr. Scott Gottlieb, Wall Street Journal, 5-29-07
• We’re seeking more data: FDA protects public health with careful analysis, not snap judgments by Andrew von Eschenbach, USA Today, 5-23-07
• Does a drug firms free lunch influence doctors? by Scott Lassman, The Boston Globe, 5-18-07
• Sometimes, what’s needed is a nudge by David Leonhardt, The New York Times, 5-16-07
• Financial Cure Overdue: America’s ailing Medicare, Social Security Programs The Atlanta Journal–Constitution, 4-26-07
• The Angel is in the Details by Henry I. Miller, TCS Daily, 4-25-07
• Responsible Medicine by Tom Coburn, Washington Times, 4-24-07
• Risky Drug Business by Richard A. Epstein, Wall Street Journal, 4-24-07
• Black Box Backfire by Gilbert L. Ross, M.D., Wall Street Journal, 4-21-07
• Hospitals Check Their Charts: Rankings Push Them to Improve Care by Steven Pearlstein, Washington Post, 4-20-07
• Do politicians know better than patients? by Jon Kyl, Real Clear Politics, 4-18-07
• Bitter Pills Wall Street Journal, 4-18-07
• Drug Danger by Dr. Scott Gottlieb, Wall Street Journal, 4-17-07
• Drugs and Demagogues by Thomas P. Stossel, M.D., The Boston Globe, 4-17-07
• Drug safety reform at the FDA New England Journal of Medicine, 4-13-07
• A year later, healthcare experiment has vital signs by John McDonough, The Boston Globe, 4-11-07
• Boomer Boomerang by Robert J. Samuelson, Washington Post, 4-11-07
• Perverse incentives in health care by John Goodman, Wall Street Journal, 4-5-07
• Shotgun Medicine, Flimsy Evidence by Dr. Eric Topol, Baltimore Sun, 4-3-07
• Restricted Treatment by Robert Goldberg, Ph.D., Washington Times, 3-29-07
• Disruptive Innovation: Can Health Care Learn From Other Industries? A Conversation with Clayton M. Christensen Health Affairs, 3-13-07
• Medicine and Markets by Dr. Scott Gottlieb, Forbes, 3-12-07
• Prescription for Trouble by Dr. Scott Gottlieb, Wall Street Journal, 3-6-07
• Why I'm Fighting – The Health Care New York Needs by Eliot Spitzer, New York Post, 3-5-07
• Medical Nihilism and the HPV Vaccine by Ivan Oransky, The Boston Globe, 3-4-07
• The Fear Industrial Complex by John Stossel, Real Clear Politics, 2-28-07
• If profit is bad, why choose Michigan? by Chuck Moss, Detroit News, 2-28-07
• Overdose of restraints could sicken industry by Michael H. Davidson, Chicago Sun-Times, 2-27-07
• Intensive Care for RomneyCare by Sally C. Pipes, Wall Street Journal, 2-26-07
• What price health? Investor's Business Daily, 2-23-07
• The Rise of In-Store Clinics – Threat or Opportunity New England Journal of Medicine, 2-22-07
• A Dog's Breakfast by Daniel L. McFadden, Wall Street Journal, 2-16-07
• Texas HPV mandate not quite compelling by Steve Chapman, Chicago Tribune, 2-15-07
• Lean New Pharma by Dr. Scott Gottlieb, Forbes, 2-14-07
• Adding up the reason's for expensive health care by Steven Pearlstein, Washington Post, 2-14-07
• The Clinical Trial by Mark Thornton, Wall Street Journal, 2-12-07
• No Perfect Pill: Safe for all shouldn't be FDA standard The San Diego Union-Tribune, 2-10-07
• My order protects life: Vaccine mandate will prevent deaths, give parents the final word USA Today, 2-9-07
• The Truth About the Drug Ads by John Calfee, The American, 2-7-07
• Fact: No link of vaccine, autism by Arthur Caplan, The Philadelphia Inquirer, 2-6-07
• Orthopedists for Vioxx Wall Street Journal, 2-3-07
• Doctoring Medicaid by Tarren Bragdon, New York Sun, 1-25-07
• Health and Taxes Wall Street Journal, 1-24-07
• State plans miss the point USA Today, 1-15-07
• No crisis of the uninsured by Mike Rosen, Rocky Mountain News, 1-12-07
• The Real Dangers of Medicare by John Calfee, New York Sun, 1-12-07
• Medicare and the Market: Government Shouldn’t Be Negotiating Prescription Prices by Mike Leavitt, Washington Post, 1-11-07
• License to Ill by Benjamin Zycher, Ph.D., National Review Online, 1-11-07
• Terminatorcare by David R. Henderson, Wall Street Journal, 1-10-07
• Medicare Part D and Prescription Drug Prices
  Policy Fact Sheet by Mark McClellan, Pacific Research Institute, 1-9-07
• Pharma in Europe: Going from Heartburn to Heart Attack? by Jurgen Reinhoudt, The American, 1-4-07
• Review and Outlook: The 100 Hours Rush Wall Street Journal, 1-4-07
• Don't infect Medicare with Price Controls by Deroy Murdock, Union Leader, 1-1-07
• The myth of the big bad drug companies by Richard A. Epstein, Los Angeles Times, 12-22-06
• We're Not Your Drugstore by Louise Crandall, New York Sun, 12-20-06
• Drug Ads: Kill the Messenger by Sally C. Pipes, New York Post, 12-19-06
• Don't Expose drug makers to business killing lawsuits Detroit News, 12-18-06
• Anti–depressants and labels Eye on FDA, 12-14-06
• Fighting Drug Fakes The New York Times, 12-12-06
• Bad Medicine New York Sun, 12-12-06
• Let's Pay Up for Alzheimer's by Newt Gingrich, by Robert Egge, Business Week, 12-11-06
• Pharmaceutical R& D Washington Times, 12-8-06
• Yes. Let the Government Bargain with Drugmakers by Karen Davenport, The Philadelphia Inquirer, 12-6-06
• No. Private Insurers are Already Getting Discounts by Robert E. Moffit, Ph.D., The Philadelphia Inquirer, 12-6-06
• Little Big Pharma Wall Street Journal, 12-6-06
• Renew Milton Friedman's Conservatism by Newt Gingrich, AEI Online, 12-4-06
• National Health Care? We're Halfway There by Daniel Gross, The New York Times, 12-3-06
• Seniors, Be Careful What You Wish For Seattle Post-Intelligencer, 12-3-06
• What's Good for Pharma is Good for America by Richard A. Epstein, The Boston Globe, 12-3-06
• Employer Sponsored, Personal, and Portable Health Insurance by John Goodman, Health Affairs, 12-1-06
• Taking Cola to Court by Walter K. Olson, City Journal, 12-1-06
• Medicaid on the Mend USA Today, 11-28-06
• Prescription for Healing Health Care by Thomas P. Hartnet, Buffalo News, 11-26-06
• The Market's Medicine Orange County Register, 11-26-06
• Ankle Deep in Medicare Madness The Globe and Mail, 11-23-06
• Drugstore Cowboys The Dallas Morning News, 11-21-06
• Questionable Cure for a Questionable Crisis: The Massachusetts Health Plan Takes Shape by Sally C. Pipes, Pacific Research Institute, 11-20-06
• A Drug Price Path to Avoid by Alberto Mingardi, Washington Post, 11-12-06
• Playing Medi-Scare Again by Newt Gingrich, Washington Times, 11-8-06
• Medicaid Advantage: A Medical Home for Dual-Eligibles by Robert B. Helms, Ph.D., by Grace-Marie Turner, Galen Institute, 11-7-06
• Mass Medical Mess by Sally C. Pipes, Washington Times, 11-5-06
• Rolling the Health Dice by Milt Freudenheim, by Reed Abelson, The New York Times, 11-4-06
• An Election on Drugs Washington Post, 11-2-06
• Paying for Performance by Elliott S. Fisher, New England Journal of Medicine, 11-2-06
• Protecting the Health of the Public—Institute of Medicine Recommendations of Drug Safety by Sheila Burke, by Bruce M. Psaty, Ph.D., New England Journal of Medicine, 10-26-06
• Building on the Successes of Health Savings Accounts by Robert E. Moffit, Ph.D., by Greg D'Angelo, Heritage Foundation, 10-20-06
• Competition Good For Your Health (Care) by Robert E. Moffit, Ph.D., Washington Times, 10-19-06
• The Medicare Drug Benefit: What Happened? by Karlyn Bowman, American Enterprise Institute, 10-19-06
• A Lesson From Europe On Health Care by David Leonhardt, The New York Times, 10-18-06
• The Dangers of Undermining Patient Choice: Lessons from Europe and Canada Institute for Policy Innovation, Galen Institute, International Policy Network, 10-18-06
• Anthrax and Lawyers by Peter Huber, Forbes, 10-16-06
• Faster FDA Cures Wall Street Journal, 10-13-06
• Fix Medicare, Not Its Prices by Michael Cannon, Cato Institute, 10-10-06
• Are Bad Drugs Coming to a Pharmacy Near You? by Henry I. Miller, Tech Central Station, 10-4-06
• Markets and Medicare Wall Street Journal, 10-4-06
• Markets and Medicare Wall Street Journal, 10-4-06
• Common Sense on Medicare Chicago Tribune, 9-25-06
• Medical Mindset by Sally C. Pipes, National Review Online, 9-21-06
• Apples and Oranges by Grace-Marie Turner, Galen Institute, 9-15-06
• Medical Tourism: Why Americans Take Medical Vacations Abroad by Diana M. Ernst, Pacific Research Institute, 9-15-06
• Medicare: The Monster at Our Door by Robert J. Samuelson, Real Clear Politics, 9-13-06
• I Cannot Support Socialized Medicine by Arnold Schwarzenegger, The San Diego Union-Tribune, 9-5-06
• Bad Medicine by Robert Goldberg, Ph.D., National Review Online, 8-28-06
• California's Real Drug Problem Investor's Business Daily, 8-24-06
• Counterfeit Drugs: Coming to a Pharmacy Near You by Wyatt Yankus, ACSH, 8-24-06
• Arnold's Raw Deal by Sally C. Pipes, Opinion Journal, 8-16-06
• Filing the Doughnut Hole by Grace-Marie Turner, Galen Institute, 8-14-06
• Curing European Health Care by Helen Disney, Wall Street Journal, 8-9-06
• Justice Scams by Ted Frank, AEI Online, 8-8-06
• Access Before Approval – A Right to Take Experimental Drugs? by Susan Okie, M.D., New England Journal of Medicine, 8-3-06
• Health Care Costs Threaten Nation’s Economic Dominance by Newt Gingrich, by Michael I. Mackness, by David Merritt, Chicago Sun-Times, 7-31-06
• Getting Moving on Health Care by John F. Kerry, The Boston Globe, 7-31-06
• Asking for a Crisis Investor's Business Daily, 7-31-06
• The Massachusetts Health Plan: Lessons for the States by Robert E. Moffit, Ph.D., by Nina Owcharenko, Heritage Backgrounder, 7-18-06
• The Health Care Choice Act: Eliminating Barriers to Personal Freedom and Market Competition by Robert E. Moffit, Ph.D., Heritage Foundation, 7-17-06
• Competition Works by Grace-Marie Turner, Galen Institute, 7-14-06
• Drug Prescription Plan Works For Seniors by Candace Miller, Detroit News, 7-12-06
• Who's In Charge? by Marc Siegel, MD, Washington Post, 7-11-06
• Bismark's Health Plan Wall Street Journal, 7-7-06
• Grading Surgeons May Be A Healthy Practice by David Wessel, Wall Street Journal, 7-6-06
• A Sucker Is Born St. Louis Post-Dispatch, 7-3-06
• Antidepressants and the Numbing–Down of America by Sally Satel, MD, AEI Online, 6-30-06
• Restraining Doctors Isn't the Answer by Stephen Hoffman, The Boston Globe, 6-29-06
• Streamlining Drug Approval by Peter J. Pitts, by Robert Goldberg, Ph.D., by Robert Peter Gale, Washington Times, 6-22-06
• Forget Vioxx? by Matthew Herper, Forbes, 6-21-06
• Medicare Mess Guaranteed to Grow by Robert E. Moffit, Ph.D., Washington Times, 6-14-06
• A Vaccination Against Complacency by Wendy Everett, The Boston Globe, 6-13-06
• Now Bring Vioxx Back Wall Street Journal, 6-8-06
• More aid will not prevent more AIDS by Philip Stevens, Bangkok Post, 6-5-06
• The Drug Benefit: A Report Card The New York Times, 6-5-06
• Drug delusions at the WHO by Andres Mejia-Vergnaud, International Policy Network, 5-23-06
• Government-Controlled Pharmaceutical Research and Development: A Recipe for Disaster by Richard Tren, by Roger Bate, AEI Online, 5-22-06
• Price Gouging is Bad Medicine by Alexander Tabarrok, Wall Street Journal, 5-20-06
• How safe is too safe? by Matthew W. Strobeck, by Tomas Philipson, by Adrian H. B. Gottschalk, by Ernst R. Berndt, Milken Institute Review, 5-19-06
• They'd Sooner Fix Medicaid by Tom Coburn, by Regina E. Herzlinger, Manhattan Institute, 5-18-06
• Evidence Based Health Policy Against Fads by Anders Sandberg, Center for the New Europe, 5-18-06
• Death's Waiting List by Sally Satel, MD, The New York Times, 5-15-06
• Try and Try Again by Grace-Marie Turner, Galen Institute, 5-12-06
• Get the Facts: Attacks on President Bush's drug plan could be costing seniors dearly Orlando Sentinel, 5-10-06
• Congress Drops the Ball on Medical Liability Reform by Bill Frist, The Seattle Times, 5-10-06
• Health Insurance Showdown Wall Street Journal, 5-9-06
• Prodigal State by Newt Gingrich, Wall Street Journal, 5-4-06
• Bad Bugs, Few Drugs by Henry I. Miller, Washington Times, 5-3-06
• Risky Business by Carl J. Schramm, Wall Street Journal Europe, 5-3-06
• Crisis du Jour or the Real Thing? by Joe Antos, American Enterprise Institute, 5-3-06
• Patient Power: The FDA Doesn’t Have to Decide Everything by John Calfee, The Weekly Standard, 5-1-06
• Competition is the Way by John Shadegg, by Jim DeMint, Washington Times, 5-1-06
• Medical Liability Repair by Stuart Weinstein, Washington Times, 4-30-06
• A Serious Senate Agenda for "Health Week" by Nina Owcharenko, by Robert E. Moffit, Ph.D., Heritage Foundation, 4-30-06
• Three simple solutions to cure Medicare prescription-plan ills by Richard G. Stefanacci, The Philadelphia Inquirer, 4-16-06
• Health Policy in Maryland and Massachusetts: A Study in Contrasts by Regina E. Herzlinger, Heritage Foundation, 4-13-06
• Rein in the Monster by John Calfee, New York Sun, 4-12-06
• Power to the Patients by Peter J. Pitts, Wall Street Journal Europe, 4-12-06
• Health Care for Everyone? We’ve Found a Way by Mitt Romney, Wall Street Journal, 4-11-06
• Massachusetts will fail by Sally C. Pipes, USA Today, 4-9-06
• The FDA and MS Wall Street Journal, 4-7-06
• Bill of Health by Arnold Kling, Wall Street Journal, 4-6-06
• Health Savings Accounts: It’s All Good by Grace-Marie Turner, Galen Institute, 4-6-06
• Favorable Medicare Access Washington Times, 4-4-06
• The Health of a Nation by Alan Hubbard, The New York Times, 4-3-06
• The Vaccine Crisis by Marilyn Webber, National Journal, 4-1-06
• Drug Makers First Target of Trial Lawyers by Stephen Hantler, Michigan Forward, 4-1-06
• Medicare? But that’s for old people by Michael Cannon, Washington Times, 4-1-06
• A Healthy Medicare Drug Plan by David Merritt, by Newt Gingrich, The Boston Globe, 3-30-06
• A Foolish Way to Fight Fraud by Steve Malanga, New York Post, 3-29-06
• Governments Restrict Access to Healthcare and Prevent Medicine Development: International Policy Network, 3-28-06
• Playing Catch-Up: The FDA, Science, and Drug Regulation by Joseph Calfee, Ph.D., American Enterprise Institute, 3-28-06
• Health-care reform: Be patient by Alex Gerber, Washington Times, 3-26-06
• Health Advisors by Grace-Marie Turner, Galen Institute, 3-24-06
• The Real Cost of AIDS in Sierra Leone by Roger Bate, Economic Affairs, 3-21-06
• Florida Empowers Health-Care Consumers by David Merritt, by Newt Gingrich, Tallahassee Democrat, 3-16-06
• Save the Medicare Benefit Washington Times, 3-15-06
• When Fear Is Deadly by Phillip K. Howard, New York Sun, 3-14-06
• Speech at Commonwealth Club by Mike Leavitt, Secretary of Health and Human Services, 3-14-06
• Sticker shock could help with healthcare costs by Newt Gingrich, by James Frogue, The Hill, 3-8-06
• The hip that changed health care history by David Gratzer, National Post, 3-7-06
• Drug Reckoning Wall Street Journal, 3-6-06
• Shop and Compare Hospital Care by Bob Moos, The Dallas Morning News, 3-5-06
• Letter to the Editor: Juryless Health Courts Could Stabilize 'Crisis' by Phillip K. Howard, Wall Street Journal, 2-28-06
• Price Transparency by Grace-Marie Turner, Galen Institute, 2-24-06
• Cancer Prognosis Wall Street Journal, 2-23-06
• Biased Doctors? by Sally Satel, MD, National Review Online, 2-23-06
• Consumers’ Role in Health Care by Jim DeMint, The State.com, 2-22-06
• Demon drugs; Industry faces chorus of critics The Oklahoman, 2-21-06
• Health savings accounts look like brain wave of the future by Michael Barone, Chicago Sun-Times, 2-21-06
• Patient Power Investor's Business Daily, 2-17-06
• Doctors, Post Your Prices by Scott W. Atlas, MD, Wall Street Journal, 2-17-06
• Pharma Pain: Canada Must Revamp its Drug Pricing Policies or Face Shortages as U.S. Demand Siphons Off Our Supply by Brett J. Skinner, National Post, 2-16-06
• Thwart Hillarycare 2006 by Robert Goldberg, Ph.D., Washington Times, 2-2-06
• What Did Those Asbestos X-Rays Really Show? by Lester Brickman, PointofLaw.com, 2-2-06
• The Health Care Opportunity Wall Street Journal, 2-1-06
• Do the math; you'll like health savings by Grace-Marie Turner, The Atlanta Journal–Constitution, 1-31-06
• The Health of the Union by George Melloan, Wall Street Journal, 1-31-06
• Under an Avalanche by Grace-Marie Turner, Galen Institute, 1-26-06
• Health Coverage Chaos by Deroy Murdock, Washington Times, 1-23-06
• Californians Should Reject Drug Importation by Tommy G. Thompson, The San Diego Union-Tribune, 1-19-06
• New England Journal of Politics Wall Street Journal, 1-16-06
• HilaryCare Returns Wall Street Journal, 1-16-06
• Keep Government Out by Daniel P. Kessler, by R. Glenn Hubbard, by John F. Cogan, AEI Online, 1-13-06
• Revolutionizing health care by Robert Goldberg, Ph.D., Manhattan Institute, 1-11-06
• California's Uninsured: Crisis, Conundrum, or Chronic Condition? by John R. Graham, Pacific Research Institute, 1-10-06
• High on the drug benefit by Grace-Marie Turner, Galen Institute, 1-6-06
• A healthy strategy Los Angeles Times, 1-4-06
• Cutting through the confusion in Part D by Joseph R. Antos, Ph.D., AEI Online, 1-4-06
• Ominous Prospects for an Aging Population Tech Central Station, 1-3-06
• Vexing Vioxx Washington Post, 1-2-06
• Prescription for trouble Consumer Reports, 1-1-06
• Mere Magazines by Thomas P. Stossel, M.D., Wall Street Journal, 12-30-05
• Lessons from Vioxx The Boston Globe, 12-19-05
• Vaccine Liability: Congress Should Give Vaccines a Shot in the Arm by Randolph W. Pate, J.D., MPH, Heritage Foundation, 12-16-05
• The Grassley Drug Plan by Robert Goldberg, Ph.D., Washington Times, 12-15-05
• New Medicaid Model by Jeb Bush, Washington Times, 12-15-05
• Gouging The Drug Companies by Peter Huber, Forbes, 12-12-05
• Expression of Concern: Bombardier et al., “Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis” by Gregory Curfman, New England Journal of Medicine, 12-8-05
• Making Sense of Drug Safety by Henry Miller, M.S., M.D., Washington Times, 12-7-05
• Don’t Monkey With Seniors Medicare Savings by Grace-Marie Turner, Galen Institute, 12-7-05
• Growing and Collapsing by Grace-Marie Turner, National Review Online, 12-6-05
• WHO’s in Charge? by Philip Stevens, National Review Online, 12-2-05
• Lawsuits Won’t Stop Pandemics by Paul A. Offit, Wall Street Journal, 12-1-05
• Confusing Choices in Medicare? by Grace-Marie Turner, Galen Institute, 11-28-05
• The "Choo-Choo Man" Party on the Outs by David Gratzer, National Review Online, 11-28-05
• AARP’s America is a Mirage by Robert J. Samuelson, Washington Post, 11-16-05
• The Senate Reconciliation Bill: Wrapping Doctors in More Medicare Red Tape by Richard Dolinar, M.D., Heritage Foundation, 11-10-05
• Flu shot priorities by Gilbert L. Ross, M.D., Washington Times, 11-9-05
• Health Care Tax Credits: Designing an Alternative to Employer-Based Coverage by Nina Owcharenko, Heritage Foundation, 11-9-05
• Public Health Care on Path to Bankruptcy by Brett J. Skinner, The Fraser Institute, 11-8-05
• Pandemics and Lawsuits by Robert Goldberg, Ph.D., Washington Times, 11-7-05
• Under fire, a giant employer offers a useful health plan USA Today, 11-7-05
• Halloween Part II: Dawn of Price Controls: Each year, Congress resurrects a bad policy by Robert Goldberg, Ph.D., Medical News Today, 11-3-05
• Prescription Drug Payola by Merrill Matthews, Center for Medical Progress, 11-3-05
• Early comments on Humeston defense verdict by Ted Frank, PointofLaw.com, 11-3-05
• Guaranteed Future Pain and Suffering: The Recent Research on Drug Price Controls by Derek Hunter, Heritage Foundation, 11-3-05
• Patent Nonsense on avian flu by Alec van Gelder, The Boston Globe, 10-31-05
• In Control of My Health by David Gratzer, New York Sun, 10-28-05
• A Comparison of Propositions 78 and 79, Prescription Drug Pricing Initiatives in the November 8, 2005, Special Election by John R. Graham, Pacific Research Institute, 10-27-05
• Baby Steps: Congressional Action on Medicaid Reform by Nina Owcharenko, Heritage Foundation, 10-27-05
• The Effect of State Regulations on Health Insurance Premiums: A Preliminary Analysis by Michael New, Heritage Foundation, 10-27-05
• May Reagan GOP R.I.P by Robert Goldberg, Ph.D., Washington Times, 10-26-05
• Values-Driven Healthcare: Freedom of Conscience for the Consumer by Robert E. Moffit, Ph.D., Heritage Foundation, 10-25-05
• Healthy profits have healing powers by Benjamin Zycher, Ph.D., Los Angeles Times, 10-25-05
• U.S. Consumers Shafted by European Price Controls by James K. Glassman, Scripps Howard News Service, 10-25-05
• Florida's Medicaid Gamble The New York Times, 10-24-05
• Hot Topic: Political Virus Wall Street Journal, 10-22-05
• Drugs companies are not on the same level as arms dealers by Andrew Jack, Financial Times, 10-15-05
• Idealistic, It’s Not: Consumers Union wrong to tout Prop. The San Diego Union-Tribune, 10-14-05
• Paying for Medicare: An Economic Look at the Program's Unfunded Liabilities by Tracy L. Foertsch, Ph.D., by Joseph R. Antos, Ph.D., Heritage Foundation, 10-11-05
• High stakes in the Hague by Johan Hjertqvist, Center for the New Europe, 10-10-05
• Counterfeit Pharmaceuticals and the Public Health by Ronald W. Buzzeo, Wall Street Journal, 10-4-05
• Medicaid’s Code Red by Louis S. Richman, The New York Times, 10-2-05
• In praise of U.S. health care by Michael Tanner, Washington Times, 10-1-05
• Good News All Around by Grace-Marie Turner, Galen Institute, 10-1-05
• The New Pill Isn't Always the Best Pill by Sally Satel, MD, National Review Online, 9-28-05
• Regime Change at the FDA Wall Street Journal, 9-27-05
• Compulsory social responsibility by Martin Krause, Washington Times, 9-27-05
• Katrina's Victims Deserve Better than Medicaid by Nina Owcharenko, Heritage Foundation, 9-26-05
• The White House Is Right To Threaten a Veto on Drug Importation by Andrew Grossman, Heritage Foundation, 9-21-05
• Medicaid is behind the decline in private health coverage by Michael Cannon, New Hampshire Union Leader, 9-19-05
• Health Care and Homeland Security: It’s Catastrophic to Have One without the Other by David Merritt, by Newt Gingrich, Chicago Tribune, 9-19-05
• The Companies Everyone Loves to Hate by Roger Bate, Wall Street Journal, 9-16-05
• The Vioxx Hex Washington Post, 9-16-05
• Command and Control: Maine’s Dirigo Health Care Program by Tarren Bragdon, Heritage Foundation, 9-15-05
• Health Savings Accounts: The News Keeps Getting Better by Derek Hunter, Heritage Foundation, 9-6-05
• Vioxx-type danger and legal frivolity by Robert Goldberg, Ph.D., Washington Times, 8-24-05
• A dangerous Vioxx verdict Chicago Tribune, 8-24-05
• Vioxx verdict’s dark side by A. Mitchell Polinsky, by Steven Shavell, The Boston Globe, 8-23-05
• Son of Sanford Wall Street Journal, 8-23-05
• Suggested side-effects - The Vioxx verdict should serve to stimulate tort reform. Financial Times, 8-23-05
• Vioxx Verdict Wall Street Journal, 8-22-05
• Ambush In Angleton by Richard A. Epstein, Wall Street Journal, 8-22-05
• The doctors' chance to lead by Edwin Coffey, by Victor Dirnfeld, by David Gratzer, National Post, 8-16-05
• Prevention is still key to fighting AIDS plague by Franklin Cudjoe, Campaign for Fighting Diseases, 8-14-05
• Canada's 'Free' Health Care Has a High Price Tag by John Fund, Wall Street Journal, 8-12-05
• Let People Choose by David Gratzer, New York Sun, 8-11-05
• Consumerism in Health Care: Early Evidence is Positive by Grace-Marie Turner, Galen Institute, 8-11-05
• OUR VIEWS: 'Paradise' pills The Press-Enterprise, 8-7-05
• OUR OPINIONS: Not buying this 'remedy' Not enough that the pharmaceutical industry plans to reduce consumer ads. FDA controls are needed, too The Atlanta Journal–Constitution, 8-5-05
• California Dreamin' by Grace-Marie Turner, Galen Institute, 8-5-05
• Health Monopoly Makes Canada Odd Nation Out by Nadeem Esmail, The Fraser Institute, 8-4-05
• Medicare: Yesterday and Tomorrow by Joseph R. Antos, Ph.D., American Enterprise Institute, 8-2-05
• Medicine for Medicaid by Tom Nerney, by Regina E. Herzlinger, Wall Street Journal, 8-2-05
• Cheaper Health Insurance Wall Street Journal, 7-25-05
• Don't fear the vaccines The Globe and Mail, 7-25-05
• Hitting targets, missing dignity by Dr. Eamonn Butler, Adam Smith Institute, 7-24-05
• Why we must invest in electronic medical records by Bill Frist, The San Francisco Chronicle, 7-24-05
• Profits and the development of drugs by Linda Gorman, Denver Post, 7-24-05
• Who's Minding Medicaid? The New York Times, 7-20-05
• Editorials/Op-ED: Vaccines and autism Washington Times, 7-15-05
• Small Leaps or Giant Steps by Dr. Scott Gottlieb, AEI Online, 7-13-05
• A Drug-Ad Ban Is Tough To Swallow by Charles Stein, The Boston Globe, 7-10-05
• Reimportation Threatens Innovation by Orrin Hatch, Roll Call, 7-7-05
• Congress Got Something Right by David Gratzer, Wall Street Journal, 7-5-05
• The Future of healthcare in Africa British Medical Journal, 7-2-05
• Opening Pandora's Pillbox by Dr. Scott Gottlieb, Health Affairs, 7-1-05
• Medicaid's Untallied Costs by Michael Cannon, Cato Institute, 7-1-05
• Power to the African People by Julian Morris, The Spectator, 6-29-05
• An end to the party line by David Gratzer, Macleans.ca, 6-14-05
• Accelerate drug approval by Robert Goldberg, Ph.D., Washington Times, 6-14-05
• A Better Prescription by Bruce Mehlman, Washington Times, 6-10-05
• The Wall Tumbles by Grace-Marie Turner, Galen Institute, 6-9-05
• FDA Disappoints Lung Transplant Patients by Dr. Scott Gottlieb, Forbes, 6-8-05
• Unequal care troubles CEO by Tom Walsh, Detroit Free Press, 6-7-05
• The WHO: A Time for Reconstitution by Richard E. Wagner, Campaign for Fighting Diseases, 6-1-05
• TAMING MEDICAID Taming NY's Medicaid beast NY taxpayers spend twice as much on Medicaid than those in the next closest state Newsday, 5-28-05
• Ensuring That All Are Equally Ill Investor's Business Daily, 5-25-05
• Health Savings Accounts for Seniors Washington Times, 5-21-05
• The FDA vs. Cancer Patients Wall Street Journal, 5-19-05
• A New Prescription for Health Care by David Gratzer, National Review Online, 5-16-05
• Innovators by Grace-Marie Turner, Galen Institute, 5-13-05
• FDA goes straight to press by Dr. Scott Gottlieb, USA Today, 5-11-05
• Health Care Won't Solve Auto Woes by Tom Bray, New York Sun, 5-11-05
• Commentary: Prescription for Disaster; The District's proposal to regulate the price of drugs would hinder scientific progress. Washington Post, 5-8-05
• A Pharmaceutical Free Lunch? by Doug Bandow, Townhall.com, 5-2-05
• How to Fix Health Care by Dan Crippen, Washington Post, 5-1-05
• Health Bulletin Center for the New Europe, 5-1-05
• Why Are Pharmaceutical Companies Gradually Abandoning Vaccines? by Paul A. Offit, Health Affairs, 5-1-05
• To spare the pain by Elizabeth Whelan, Washington Times, 4-31-05
• Is the FDA Broken? by Joseph Calfee, Ph.D., Tech Central Station, 4-30-05
• A Private Obsession by Paul Krugman, The New York Times, 4-29-05
• The 'European disease' by Robert Goldberg, Ph.D., Washington Times, 4-28-05
• A Lethal Guardian: The Canadian Government's Ban on Prescription Drugs by John R. Graham, The Fraser Institute, 4-28-05
• FDA policy reforms sorely needed to improve safety by Henry Miller, M.S., M.D., Detroit Free Press, 4-28-05
• FDA in a pain-pill panic Washington Times, 4-26-05
• Cracks in High Drug Prices; Change is in the air as Congress looks at legalizing orders from foreign companies. Los Angeles Times, 4-22-05
• Taxed to Death by Jasson Urbach, by Richard Tren, by Roger Bate, AEI-Brookings Joint Center for Regulatory Studies, 4-21-05
• Don’t get old by Tony Blankely, Washington Times, 4-20-05
• WHAT'S NEEDED ON PRESCRIPTION LABELS by Steven Wolosin, by Lisa M. Schwartz, The Boston Globe, 4-20-05
• The Drug Approval Pendulum by Anne Applebaum, Washington Post, 4-19-05
• Bargain fares on Rx express? by Elizabeth Whelan, Washington Times, 4-18-05
• Letters to the Editor: Dying While Waiting for the FDA to Act Wall Street Journal, 4-15-05
• Medical R&D Miracle by Doug Bandow, Washington Times, 4-12-05
• The Top Ten Reasons for Medicaid Reform by Nina Owcharenko, Heritage Foundation, 4-12-05
• Data Do Not Support Ban on Silicone Breast Implants by Sally Satel, MD, USA Today, 4-11-05
• The Secret Truth: Parents Used to Accept Routine Vaccinations For Their Children Without a Second Thought. by Darshak Sanghavi, The Boston Globe, 4-5-05
• Banks: The New HMOs by Dr. Scott Gottlieb, Forbes, 4-4-05
• What ails health care by David Gratzer, The Public Interest, 4-1-05
• Kianna's Legacy Wall Street Journal, 3-29-05
• A Malaria Success The New York Times, 3-27-05
• A BALANCED LOOK AT COX-2 DRUGS by Timothy Hla, The Boston Globe, 3-25-05
• REVIEW & OUTLOOK (Editorial): How About a 'Kianna's Law'? Wall Street Journal, 3-24-05
• Putting Profits ahead of Patients by Dr. Scott Gottlieb, Forbes, 3-17-05
• A Troubling Drug Combination The New York Times, 3-15-05
• Rules Are Killing Good Science by Henry Miller, M.S., M.D., Los Angeles Times, 3-14-05
• The Quality Cure? The New York Times, 3-13-05
• RX FOR MEDICARE by Lois Quam, The Boston Globe, 3-11-05
• Health Policy on a Budget by Joseph R. Antos, Ph.D., Health Policy Outlook, American Enterprise Institute, 3-10-05
• The costs of health care by Doug Bandow, Washington Times, 3-2-05
• Drug Twilight Zone Wall Street Journal, 3-2-05
• BACK TO SANITY ON COX-2 DRUGS ; PATIENTS, DOCTORS CAN WEIGH RISK, REWARDS Rocky Mountain News, 2-28-05
• Reducing Barriers to the Development of High Quality, Low Cost Medicines: A proposal for Reforming the Drug Approval Process International Policy Network, 2-28-05
• Editorial: Too Strict at NIH Washington Post, 2-23-05
• Commentary: A safer Vioxx? Try this remedy by Joe Torg, The Philadelphia Inquirer, 2-23-05
• Commentary: Good Drug, Bad Customers - II by Holman W. Jenkins Jr., Wall Street Journal, 2-23-05
• Viable Vioxx Wall Street Journal, 2-22-05
• F.D.A. Moves Toward More Openness With the Public by Gardner Harris, The New York Times, 2-20-05
• Medicating the FDA by Henry Miller, M.S., M.D., Washington Times, 2-17-05
• Medicaid needs Surgery by David Gratzer, The Weekly Standard, 2-14-05
• Brouhaha by Grace-Marie Turner, Galen Institute, 2-11-05
• Science Needs A Profit Motive by Steven Pearlstein, Washington Post, 2-4-05
• Medical Bankruptcy Galen Institute, 2-4-05
• Pharma Furor by Richard A. Epstein, Legal Affairs, 2-1-05
• Health of the Union by David Gratzer, Wall Street Journal, 1-26-05
• The Gates Vaccinations Washington Post, 1-25-05
• HSAs Are A-OK by Andy Laperriere, Wall Street Journal, 1-24-05
• The Budget Health Shock by Sebastian Mallaby, Washington Post, 1-24-05
• The burden of staying alive; It's the drugs you can't get that might kill you by Dr. Scott Gottlieb, Chicago Tribune, 1-21-05
• Call 'Negotiated' Drug Prices What They Really Are: Price Controls by Benjamin Zycher, Ph.D., Los Angeles Times, 1-21-05
• Some Gene Research Just Isn't Worth the Money by Keith Humphreys, by Sally Satel, MD, The New York Times, 1-18-05
• FDA Moves Cancer Cures into the Slow Lane by Dr. Scott Gottlieb, Forbes, 1-18-05
• A Gift for Drug Makers by Bob Herbert, The New York Times, 1-14-05
• Editorial: Drug Trade Washington Post, 1-13-05
• The New Heart Disease Threat The New York Times, 1-11-05
• An Overdose of Ads The Boston Globe, 1-6-05
• The Life and Times of Ivermectin - A Success Story by Andy Crump, by Satoshi Őmura, Nature, 1-4-05
• Drug import plan sags USA Today, 1-3-05
• Painkiller panic by Alan Reynolds, Washington Times, 1-2-05
• Medicaid Rx Wall Street Journal, 1-2-05
• How Technocrats are Taking Over the Practice of Medicine: A Wake-Up Call to the American People by Twila Brase, Citizens Council on Health Care, 1-1-05
• Do Not Operate Heavy Equipment While Reading This by Holman W. Jenkins Jr., Wall Street Journal, 12-29-04
• The Right Road To Safe Drugs by Robert Goldberg, Ph.D., New York Post, 12-28-04
• Prescription for Confusion The New York Times, 12-28-04
• A World Of Hurt by William Safire, The New York Times, 12-27-04
• Demonizing the drug business by Deroy Murdock, Washington Times, 12-27-04
• Don’t Blame Canada by Robert Goldberg, Ph.D., National Review Online, 12-23-04
• The Painkiller Panic Wall Street Journal, 12-23-04
• Attacks on Vioxx don't ad up by Paul Mulshine, The Star-Ledger, 12-23-04
• The Price of Too Much Caution by Dr. Scott Gottlieb, New York Sun, 12-22-04
• A Prescription for Health by David Gratzer, National Review Online, 12-21-04
• REVIEW & OUTLOOK (Editorial) Pazdur's Revenge Wall Street Journal, 12-20-04
• Pharmaceutical Group Chiefs March to Individual Beats by Greg Critser, Los Angeles Times, 12-20-04
• Punishing drugmakers for doing good by Doug Bandow, The San Diego Union-Tribune, 12-16-04
• U.S. Health Care Needs a Spark by Newt Gingrich, The Philadelphia Inquirer, 12-15-04
• Fixing Medicare by Laurence J. Kotlikoff, Forbes, 12-13-04
• The High Cost of Cheap Drugs by Jacob Arfwedson, Wall Street Journal Europe, 12-13-04
• The Bell Curve by Atul Gawande, The New Yorker, 12-11-04
• No Silver Bullet by Grace-Marie Turner, Galen Institute, 12-10-04
• Capital: Time to Cure the Health-Choice Headache by David Wessel, Wall Street Journal, 12-9-04
• Minnesota's Health Care Gamble by David Broder, Washington Post, 12-9-04
• Medical progress; Health breakthroughs worth the price by Robert Goldberg, Ph.D., Washington Times, 12-7-04
• HillaryCare in Tennessee Wall Street Journal, 12-6-04
• Letters to the Editor: Patient Data Could Lead to Scientific Insights by Dr. Scott Gottlieb, Wall Street Journal, 12-3-04
• How to Improve Drug Safety by William B. Schultz, Washington Post, 12-2-04
• In praise of Big Pharma's me-too drugs. by John Gapper, Financial Times, 12-2-04
• Commentary: A Culture Of Subsidies Inflates Costs by Steven Pearlstein, Washington Post, 12-1-04
• EDITORIAL: Healing the FDA from within The Star-Ledger, 11-30-04
• Editorial: Looking for Adverse Drug Effects The New York Times, 11-27-04
• Commentary: The Curse of Too Much Caution by Henry Miller, M.S., M.D., Wall Street Journal, 11-26-04
• A prescription for sanity by Mortimer B. Zuckerman, U.S. News & World Report, 11-22-04
• Commentary: Why new drugs cost so much by Deroy Murdock, Washington Times, 11-22-04
• REVIEW & OUTLOOK (Editorial): The Trials of Merck Wall Street Journal, 11-18-04
• On the Contrary: Open Season on Others' Ideas by Daniel Akst, The New York Times, 11-14-04
• BOOKS: Why Canada isn't the answer to health care by Elizabeth Whelan, Washington Times, 11-14-04
• Commentary: Health Care: Beyond Markets Washington Post, 11-11-04
• Commentary: Was Withdrawing Vioxx the 'Right Thing to Do'? by Holman W. Jenkins Jr., Wall Street Journal, 11-10-04
• Welcome to our discussion on medical malpractice by James R. Copland, PointofLaw.com, 11-10-04
• Commentary: Shortages beyond flu shots by Jennifer Brower, Washington Times, 11-9-04
• Editorial: Medicine Tests Washington Post, 11-8-04
• What Federal Workers Are Doing Today that You Can't by Robert E. Moffit, Ph.D., Heritage Foundation, 11-8-04
• EDITORIAL: The answer isn't in Canada The Star-Ledger, 11-2-04
• Letter to the Editor: Europe’s Drug Import Example by Panos Kavanos, Washington Post, 10-30-04
• Commentary: A Booster Shot For Vaccines: New technology could speed development and keep the medicine chest stocked by John Carey, Business Week, 10-25-04
• Vaccine vacuity by Tom Bray, Washington Times, 10-25-04
• What Ails John Kerry’s Drug Plan? The Globe and Mail, 10-24-04
• Editorial: Flu Wars Washington Post, 10-23-04
• Kerry's toxic drug plan by Robert Goldberg, Ph.D., Washington Times, 10-22-04
• Kerry Win: Bad Medicine For Health Care by Dr. Scott Gottlieb, Forbes, 10-22-04
• How to Get Vaccines, Not Just Viagra Los Angeles Times, 10-19-04
• Kerrycare: This Plan Is Bad for Our Health The Philadelphia Inquirer, 10-17-04
• Imports Can’t Cure Drug Prices Detroit Free Press, 10-15-04
• Booming Internet Drug Sales to Americans are a Prescription for Disaster in Canada The Globe and Mail, 10-14-04
• Infectious Politics Wall Street Journal, 10-14-04
• HSA Man v. Healthzilla Wall Street Journal, 10-12-04
• Big-Biz Bailout New York Post, 10-12-04
• Big Pharma? Think Again Wall Street Journal, 10-12-04
• A Hit Job on the Drug Companies The Standard Reader, 10-11-04
• The Reimportation Blues Wall Street Journal, 10-11-04
• Vaccine Development Needs a Booster Shot Washington Times, 10-10-04
• "Hollywood" Extortion by Robert Goldberg, Ph.D., Washington Times, 10-5-04
• Beware of Doing More Harm by Ruth Rosenberg, Washington Post, 10-3-04
• Money is the Catalyst for Good Medicine by Charles Stein, The Boston Globe, 10-3-04
• Good Riddance to a Bad Drug by Dr. Eric Topol, The New York Times, 10-2-04
• A Vioxx Elegy Wall Street Journal, 10-1-04
• The Free-Market Cure : Republicans, not John Kerry, could provide the right medicine for our health-care system. by David Gratzer, National Review Online, 9-28-04
• The Nation: Venture Medicine: Health Care Costs Are a Killer, but Maybe That's a Plus by Steve Lohr, The New York Times, 9-26-04
• Drug companies under attack by Elizabeth Whelan, Washington Times, 9-21-04
• Health Savings Accounts and the FEHBP: Perfect Together by Andrew Grossman, by Robert E. Moffit, Ph.D., Heritage Foundation, 9-21-04
• ECONOMIC VIEWPOINT A Prescription For Health-Care Reform by R. Glenn Hubbard, Business Week, 9-20-04
• An IT Trojan horse ... Feds should stay out of ‘evidence-based’ medicine by Regina E. Herzlinger, Modern Healthcare, 9-14-04
• Lessons of Success: What Congress Can Learn from the Federal Employees Program by Robert E. Moffit, Ph.D., Heritage Foundation, 9-14-04
• EDITORIAL: The drug makers' problem The Star-Ledger, 9-13-04
• Bad Medicine? The data on anti-depressants and child suicide aren’t conclusive. by Sally Satel, MD, National Review Online, 9-12-04
• Power to the patient by Scott W. Atlas, MD, Washington Times, 9-8-04
• Clinton Got Quick Care, Unlike Canadian Heart Patients by Michael Cannon, Cato Daily Commentary, 9-8-04
• Consumer Driven Healthcare: Lessons from Switzerland by Regina E. Herzlinger, The Journal of the American Medical Association, 9-8-04
• What Health Insurance Crisis? by David Gratzer, Los Angeles Times, 8-29-04
• America's Failing Health by Paul Krugman, The New York Times, 8-27-04
• Commentary: How to Heal Health Care by Hillary Clinton, by Bill Frist, Washington Post, 8-25-04
• Commentary: In search of the next old thing - The copycat culture of America's drug industry by Marcia Angell, The Star-Ledger, 8-22-04
• Editorial: Cover These Treatments by Frank R. Lichtenberg, Washington Post, 8-20-04
• There's a Cure for Frivolous Drug Lawsuits by Henry Miller, M.S., M.D., Los Angeles Times, 8-16-04
• Time for a Drug Test Registry by Marcia Angell, Washington Post, 8-13-04
• Mid-year at the FDA highlights permanent problem by Ken Howard, Nature, 8-9-04
• Lower Cholesterol Without Drugs by Dean Ornish, Washington Post, 8-8-04
• Pharmaceutical Price Controls in OECD Countries by Kevin A. Hassett, Department of Commerce, 8-3-04
• From the analyst's couch: Statin switch to OTC by Martyn Link, Nature, 8-1-04
• Drug Dealing Washington Post, 7-31-04
• Innovative drugs cost patients less in the long run by Kerri Houston, Chicago Sun-Times, 7-31-04
• Health-care fantasies by Richard Ralston, Washington Times, 7-29-04
• Drug Industry Set Pace for Armstrong Victory by David Gratzer, Investor's Business Daily, 7-27-04
• How Tightly Do Ties Between Doctor and Drug Company Bind? by Abigail Zuger, M.D., The New York Times, 7-27-04
• Studies Show Temporary Drug Program Offers Value to Seniors by Grace-Marie Turner, Galen Institute, 7-26-04
• Health Savings Accounts Gain Popularity by Grace-Marie Turner, Galen Institute, 7-26-04
• Dems Win Round One in Hinchey v. Troy by Robert L. Pollock, Wall Street Journal, 7-26-04
• The Sacking of Troy by Robert Goldberg, Ph.D., Washington Times, 7-26-04
• Free health care? by Walter E. Williams, Washington Times, 7-22-04
• A Shortsighted Path To Cheaper Drugs; Drug Reimportation Will Curtail Research Rocky Mountain News, 7-21-04
• Debunking the Myths of Drug Importation by Nina Owcharenko, Heritage Foundation, 7-20-04
• Pause for prescription safety Washington Times, 7-17-04
• The Medicare Discount Drug Cards: One Month In by Derek Hunter, Heritage Foundation, 7-15-04
• Wishful Thinking by Robert E. Windom, Washington Times, 7-8-04
• Reaping What Biopharming Sows by Henry Miller, M.S., M.D., Washington Times, 7-6-04
• Drug Discount Cards: A Second Opinion by Derek Hunter, Washington Times, 7-6-04
• Letter to the Editor: Saying No to Cheap Drugs by Robert Goldberg, Ph.D., Washington Post, 7-3-04
• Drug Wars: Perils of Importing Drugs from Canada by Robert Goldberg, Ph.D., Ripon Forum, 7-1-04
• Health Savings Accounts: Early experience shows broad appeal by Grace-Marie Turner, Galen Institute, 6-23-04
• The Cheap Drug Trap by Laurence J. Kotlikoff, The Boston Globe, 6-21-04
• Paxil Man Wall Street Journal, 6-21-04
• Make prescription drugs affordable by Thomas M. Ryan, Chicago Tribune, 6-18-04
• Rx Roulette On the Internet by Norm Coleman, Wall Street Journal, 6-17-04
• Attacking drug makers is no cure by R. Glenn Hubbard, Financial Times, 6-16-04
• Reagan's Medical Revolution by Robert Goldberg, Ph.D., Washington Times, 6-9-04
• Gammons' Law by David Gratzer, Financial Post, 5-27-04
• Less Is More by David Gratzer, National Review Online, 5-27-04
• From HillaryCare to KerryCare by David Gratzer, The Weekly Standard, 5-24-04
• Of Markets and Men by Robert Goldberg, Ph.D., Washington Times, 5-11-04
• Evaluating Doctors with Medicare Data The New York Times, 4-12-04
• Beware the pitfalls of "evidence-based medicine" by Grace-Marie Turner, Galen Institute, 3-24-04
• It's an Election, Stupid by Robert Goldberg, Ph.D., Washington Times, 3-22-04
• Wanted: Leadership at the FDA: A life-and-death gap to fill by David Gratzer, National Review Online, 3-2-04
• Consumer-Driven Health Care: Freeing Providers to Innovate by Regina E. Herzlinger, Healthcare Financial Management, 3-1-04
• Consumer-Driven Health Care: Taming the Health Care Cost Monster by Regina E. Herzlinger, Journal of Financial Service Professionals, 3-1-04
• Navigating the Anticommons for Pharmaceutical Patents by Richard A. Epstein, by Bruce N. Kuhlik, John. M. Olin Law and Economics Working Paper, 3-1-04
• Medicare hypocrisy by Robert Goldberg, Ph.D., Washington Times, 2-16-04
• Cadbury Replaces Cholera: Can government make us healthier? by David Gratzer, National Review Online, 2-12-04
• False compassion by Robert Goldberg, Ph.D., Washington Times, 2-5-04
• When Family Matters Most by Robert Goldberg, Ph.D., Washington Times, 1-23-04
• More Market, Less Straightjacket by Regina E. Herzlinger, Wall Street Journal, 1-22-04
• Vermont’s Badly Managed Care: Dean's health care record as governor is nothing to brag about by David Gratzer, The Weekly Standard, 1-12-04
• Making Medicare Reform Work: Getting on with business by Robert Goldberg, Ph.D., National Review Online, 12-9-03
• The Real Work's Ahead by David Gratzer, New York Post, 12-9-03
• Beyond Medicare reform by Robert Goldberg, Ph.D., Washington Times, 11-28-03
• Back in the U.S.S.R. by Regina E. Herzlinger, Wall Street Journal, 11-26-03
• Expanding Regret: Bad Medicare prescription on a fast track to law by David Gratzer, National Review Online, 11-24-03
• Endorse Medicare by Robert Goldberg, Ph.D., Washington Times, 11-20-03
• Prix-Fixe Rip-Off by Regina E. Herzlinger, Wall Street Journal, 6-13-03
• Health Care Coverage and Drug Costs - The Candidates Speak Out by George W. Bush, by John F. Kerry, New England Journal of Medicine, 10-28-01

• Explaining Pharmaceutical R & D Growth Rates at the Industry Level: New Perspectives and Insights, AEI-Brookings Joint Center for Regulatory Studies, December 2003
• Prices and Availability of Pharmaceuticals: Evidence from Nine Countries, Health Affairs, October 2003
• Pharmaceutical Price Controls and Entry Strategies, NBER Conference Paper, June 2003
• The Economics of Price Regulation and Innovation, AEI-Brookings Joint Center for Regulatory Studies, June 2004
• MarketWatch: Doughnut Holes And Price Controls, Health Affairs, July 2004
• From The Field: Closing The Doughnut Hole: No Easy Answers, Health Affairs, July 2004
• The Role of Information in Medical Markets: An Analysis of Publicly Reported Outcomes, NBER Working Paper, May 2004
• Trends in U.S. Health Insurance Coverage, 2001-2003, Center for Studying Health System Change Tracking Report No. 9, August 2004
• Views of the New Medicare Drug Law: A Survey of People On Medicare, Kaiser Family Foundation/Harvard School of Public Health, August 2004
• Inappropriate Prescribing for Elderly Americans in a Large Outpatient Population, Archives of Internal Medicine, August 2004
• Assessment of Beneficiary Savings in the Medicare Drug Discount Card Program, The Lewin Group, August 2004
• Which Medical Conditions Account For The Rise In Health Care Spending?, Health Affairs, August 2004
• Treatment Of People With Mental Illness: A Decade-Long Perspective, Health Affairs, August 2004
• Antidepressants and the Risk of Suicidal Behaviors, The Journal of the American Medical Association, July 2004
• MMR vaccination and pervasive developmental disorders: a case-control study, The Lancet, September 2004
• Analyzing the Kerry and Bush Health Proposals: Estimates of Cost and Impact, American Enterprise Institute, September 2004
• Effects Of Generic-Only Drug Coverage In A Medicare HMO, Health Affairs, September 2004
• The Value of Life and the Rise in Health Spending, NBER Working Paper 10737, September 2004
• Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process, NBER Working Paper No. w10822, October 2004
• A Critique of the Public Citizen and TB Alliance Reports, Tufts Center for the Study of Drug Development, November 2004
• The Effect of Drug Vintage on Survival: Micro Evidence from Puerto Rico’s Medicaid Program, NBER Working Paper No. w10884, November 2004
• Are Drug Price Controls Good for Your Health?, Center for Medical Progress Report, December 2004
• Report on Prescription Drug Importation, HHS Task Force on Drug Importation, December 2004
• The Interaction of Public and Private Insurance: Medicaid and the Long Term Care Insurance Market, NBER Working Paper No. w10989, December 2004
• The Distortionary Effects of Government Procurement: Evidence from Medicaid Prescription Drug Purchasing, NBER, November 2004
• More Evidence on Cardiovascular Risks of COX-2 Inhibitors, Other NSAIDs, Medscape, January 2005
• The Cost of U.S. Pharmaceutical Price Reduction, NBER Working Paper Program No. 11114, February 2005
• Estimating the Impact of Medical Innovation, NBER Working Paper No. 11109, February 2005
• Assessing Consumer Gains from a Drug Price Control Policy in the U.S., NBER Working Paper, February 2005
• High Cost Medicare Beneficiaries, Congressional Budget Office, May 2005
• Financial Anatomy of Biomedical Research, The Journal of the American Medical Association, September 2005
• Older Drugs, Shorter Lives? An Examination of the Health Effects of the Veterans Health Administration Formulary, Center for Medical Progress, October 2005
• Early Experience With Pay-for-Performance, The Journal of the American Medical Association, October 2005
• Assessing the Safety and Efficacy of the FDA: The Case of the Prescription Drug User Fee Acts, NBER, November 2005
• Making Markets Work: Five Steps To A Better Health Care System, Health Affairs, November 2005
• Evaluating the Efficiency of California Providers in Caring for Patients with Chronic Illnesses, California Healthcare Foundation, November 2005
• Health Savings Accounts: Early Estimates Of National Take-Up, Health Affairs, December 2005
• Cutting Drug Copayments For Sicker Patients Can Cut Hospitalizations and Save Money, RAND Corporation, January 2006
• Medical Bankruptcy: Myth vs. Fact, Health Affairs, February 2006
• Methods Commonly Used To Create “Report Cards” May Overestimate the Quality of Health Care, Medical Care, February 2006
• Critical Path Opportunities Report, FDA News, March 2006
• An Exploratory Analysis of Pharmaceutical Price Disparities and Their Implications Among Six Developed Nations, American Enterprise Institute, April 2006
• "Costs and Benefits of Health Information Technology", Agency for Healthcare Research and Quality, April 2006
• Intensive Medical Care and Cardiovascular Disease Disability Reductions, NBER, May 2006
• Medical Malpractice Awards, Insurance, and Negligence: Which Are Related?, Manhattan Institute, May 2006
• Health Insurance and Job Creation by the Self-Employed, AEI-Brookings Joint Center for Regulatory Studies, May 2006
• Consumer-Directed Health Plans: Small but Growing Enrollment Fueled by Rising Cost of Health Care Coverage, Government Accountability Office, April 2006
• Preventing Medication Errors: Quality Chasm Series, Institute of Medicine, July 2006
• The Value of Medical Spending in the U.S.: 1960-2000, New England Journal of Medicine, August 2006
• The State of Health Care Quality, National Center for Quality Assurance, September 2006
• The Future of Drug Safety: Promoting and Protecting the Health of the Public, Institute of Medicine, September 2006
• Aetna Releases Broadest Study to Date of Consumer Directed Plans, Aetna News, October 1006
• The Rise In Spending Among Medicare Beneficiaries: The Role Of Chronic Disease Prevalence And Changes In Treatment Intensity, Health Affairs, October 2006
• Heart Attack Risks, Pain Relief Similar for Most Osteoarthritis Drugs, Agency for Healthcare Research and Quality, September 2006
• Health Care Savings from Personalizing Medicine Using Genetic Testing: The Case of Warfarin, AEI-Brookings Joint Center for Regulatory Studies, November 2006
• European Pharmaceutical Price Regulation, Firm Profitability, and R&D Spending, National Bureau of Economic Research Digest, November 2006
• Evaluating Effects of Tax Preferences on Health Care Spending and Federal Revenues, NBER, December 2006
• Integrated Insurance Design in the Presence of Multiple Medical Technologies, NBER, January 2007
• Pharmacogenomics: an Assessment of Market Conditions and Competition, Academy Health, March 2007
• Care Patterns in Medicare and Their Implications for Pay for Performance, New England Journal of Medicine, March 2007

• Managing the Cost of Drugs in Medicine: Is Restricted Access the Answer?, Center for Medical Progress Forum, Speaker(s): Michael Weber, M.D., March 2004
  Transcript Available
• Drug Prices and the Rising Cost of Health Care, Center for Medical Progress Speaker Series, Speaker(s): J. D. Kleinke, October 2003
  Transcript Available
• Saving Medicare for the 21st Century, Center for Medical Progress Luncheon Symposium, Speaker(s): Tommy G. Thompson, June 2003
  Transcript Available
• The NHLBI/ALLHAT Blood Pressure Drug Study: Science or Politics, Center for Medical Progress Forum, Speaker(s): Robert Goldberg, Ph.D., Mark Houston, M.D., Ralph Hawkins M.D., Franz Messerli, M.D., Michael Weber, M.D., March 2003
  Transcript Available
• The Right Prescription For Medicare Drug Coverage, Center for Medical Progress Conference, Speaker(s): Robert Goldberg, Ph.D., Susan Horn, Ph.D., John R. Graham, Ralph Hawkins M.D., Joseph R. Antos, Ph.D., Grace-Marie Turner, Ron Pollack, February 2003
  Transcript Available
• The FDA and the Future of Medical Innovation, Center for Medical Progress Luncheon Symposium, Speaker(s): Mark McClellan, May 2003
• Solving the Vaccine Shortage: Market Solutions or Government Intervention?, Center for Medical Progress Conference, Speaker(s): Duane Parde, Robert Goldberg, Ph.D., Wayne Pisano, Jerome Klein, M.D., Henry Miller, M.S., M.D., July 2002
• Medical Progress and the FDA: Our Future in the Balance, Center for Medical Progress Forum, Speaker(s): Robert Goldberg, Ph.D., Alan Slobodin, Joseph Calfee, Ph.D., Joseph DiMasi, Ph.D., June 2002

• Who Pays for Efficiency? The New York Times, 6-11-07
• Milkshake drug to 'feed' brain cells among promising Alzheimer's experiments Associated Press Newswires, 6-11-07
• Who Pays for Efficiency? The New York Times, 6-11-07
• Mandatory Coverage Is Easier Said Than Done The New York Times, 6-11-07
• Giuliani Health Proposal Seeks Individual Coverage; Candidate to Unveil Market Based Plan Easier on Employers Wall Street Journal, 6-6-07
• Antipsychotics may bear fatal risks The Globe and Mail, 6-5-07
• FDA Remains Unsettled in Wake of New Questions The New York Times, 5-31-07
• Why Health Care No Longer Makes Politicians Leery Wall Street Journal, 5-30-07
• GlaxoSmithKline shares fall after report shows U.S. doctors shunning Avandia drug Associated Press, 5-29-07
• Facing cancer without insurance Cleveland Plain Dealer, 5-28-07
• Doctors' list puts a price on care Los Angeles Times, 5-28-07
• For drug makers, a downside to full disclosure The New York Times, 5-23-07
• Lawyers forecast a flood of Avandia litigation Reuters News, 5-23-07
• Free NHS a mirage, say doctors Telegraph, 4-25-07
• Wal-Mart to open 400 in-store clinics Reuters News, 4-24-07
• Anemia drug trial's tardiness at issue Los Angeles Times, 4-24-07
• Covering the uninsured, but only up to $25,000 Wall Street Journal, 4-18-07
• Drug safety bill would limit direct-to-consumer-ads; industry claims free speech violation Associated Press, 4-17-07
• AOL Founder Hopes to Build New Giant Among a Bevy of Health Care Web Sites The New York Times, 4-16-07
• Mass. Health plan finds cost is too high for 20% of people USA Today, 4-13-07
• Abbott to cut AIDS drug cost in poor nations Chicago Tribune, 4-11-07
• Lessons of Heart Disease, Learned and Ignored The New York Times, 4-8-07
• Congress Seeks Compromise on Generic Biotechnology Drugs The New York Times, 4-8-07
• Your drug gets pulled? What now? Wall Street Journal, 4-5-07
• Did Daniel's acne medication kill him? Chicago Sun-Times, 4-4-07
• More people taking advantage of health savings accounts The Star-Ledger, 4-2-07
• Drug-proof TB strain poses ethical bind Associated Press, 4-2-07
• Pediatric Study Costs Rose Substantially from 2000 as Complexity Grew Tufts Center for the Study of Drug Development, 3-13-07
• High Deductibles cut down on emergency room visits Boston Herald, 3-13-07
• Ex-Chief Urges FDA to Mine Databases Associated Press, 3-12-07
• New Generation of Stents Awaits FDA Approval Wall Street Journal, 3-8-07
• Kennedy urges tough tests for generic biologic drugs The Boston Globe, 3-7-07
• AARP: Prescription Drug Prices Up; Trade Group Calls AARP Report Inaccurate and Misleading WebMD, 3-6-07
• Off label use common in kids UPI, 3-5-07
• Embattled FDA chief fights back Houston Chronicle, 3-4-07
• Report Blasts FDA's System to Track Drugs Wall Street Journal, 3-3-07
• Emerging Drugs Show Promise Against HIV Wall Street Journal, 2-28-07
• Bargaining Down That CT Scan Is Suddenly Possible The New York Times, 2-27-07
• Independent Lens; Counter-detailers help doctors wade through drug company marketing The Boston Globe, 2-27-07
• New drug to fight cancer may get the cold shoulder Chicago Tribune, 2-27-07
• Clinical Trials: Are Drugmakers' Studies Biased? Newsweek, 2-26-07
• Judge Rules Drug Documents Must Be Returned to Eli Lilly The New York Times, 2-14-07
• Perry orders cancer virus vaccine for young girls Houston Chronicle, 2-3-07
• Drug Industry Faces Bitter Pill: Congress Proposes Tougher Regulation, Cheaper Medications Wall Street Journal, 2-2-07
• F.D.A. widens safety reviews of new drugs The New York Times, 1-31-07
• FDA Proposes New Measures to Strengthen Drug Safety Under PDUFA Reauthorized User Fee Program FDA News, 1-11-07
• Limited Menu: Japan’s ‘Cancer Refugees’ Demand More Options – Patients Decry System That’s Frugal, Universal but Restricts Choices Wall Street Journal, 1-11-07
• CBO Faults Medicare Drug Plan Associated Press, 1-11-07
• Experts Fault House Bill on Medicare Drug Prices; Comparison Called Invalid Washington Post, 1-11-07
• Congress mulls how to expand U.S. health insurance Reuters News, 1-10-07
• Gov. Offers Bold Prescription Los Angeles Times, 1-9-07
• Healthcare Spending Eases Off Los Angeles Times, 1-9-07
• Scientists See Potential in Amniotic Stem Cells: They are Highly Versatile and Readily Available Washington Post, 1-8-07
• Millions save money on Medicare Program Associated Press Newswires, 1-1-07
• Health Care Gold Mines: Middlemen Strike it Rich Wall Street Journal, 12-29-06
• New Warnings Proposed For Over–the–Counter Drugs The New York Times, 12-20-06
• New Drugs Declining, Research Costs Increasing, GAO Says Washington Post, 12-20-06
• The more you pay, the better the care? Think Twice The New York Times, 12-17-06
• Medicare Links Doctors’ Pay to Practices The New York Times, 12-12-06
• Democratic plan would require HHS secretary to negotiate drug costs San Francisco Examiner, 12-11-06
• FDA Proposes Rules Overhaul to Expand Availability of Experimental Drugs FDA News, 12-11-06
• High costs send patients overseas for care Charlotte Observer, 12-10-06
• McMedical Care Governing Magazine, 12-1-06
• Medicaid Spending Sees First Decline USA Today, 11-27-06
• Success of Drug Plan Challenges Democrats Washington Post, 11-26-06
• Administration Opposes Democrat’s Plan For Negotiating Medicare Drug Prices The New York Times, 11-13-06
• New Push for Medical Legislation Expected Baltimore Sun, 11-12-06
• California Price Curbs Alarm Drug Makers The Boston Globe, 11-11-06
• As Drug Prices Climb, Democrats Find Fault With Medicare Plan The New York Times, 11-6-06
• Seniors Seek An Advantage The Dallas Morning News, 11-6-06
• Generic Drugs: Shop Around for the Best Deals Consumer Reports, 11-1-06
• Employers, Insurers Push Generics Harder Wall Street Journal, 10-31-06
• Health Savings Accounts Slow to Catch on Among Insured The Dallas Morning News, 10-24-06
• Plans Help to Close the Gap Houston Chronicle, 10-21-06
• Confident Democrats Draft Broad Health Care Agenda The New York Times, 10-20-06
• FDA Creates Express Lane for Approving Some Generic Drugs Los Angeles Times, 10-19-06
• Drug Reactions Send 700,000 Yearly to ER Baltimore Sun, 10-17-06
• Two doctors sound alarm on heart stents The Miami Herald, 10-13-06
• A Poor Report Card The Economist, 10-12-06
• States Take Lead On Health Care As Budget Pinch Forces Reform Investor's Business Daily, 10-11-06
• Report Faults FDA on Drug Safety Washington Post, 10-10-06
• Health Care Costs Rise Twice as Much as Inflation The New York Times, 9-27-06
• Coalition Launches Campaign to Increase the FDA's Budget The Boston Globe, 9-26-06
• Millions of Seniors Facing Medicare 'Doughnut Hole' Washington Post, 9-25-06
• FDA Told U.S Drug System Is Broken Washington Post, 9-23-06
• Target Offers Cheap Drugs Too The Miami Herald, 9-23-06
• Study Finds Higher Risk of Heart Attack with Vioxx The New York Times, 9-13-06
• Government Sets Higher Medicare Rates and New Surcharge The New York Times, 9-13-06
• Study Finds Health Care Good Value Despite Costs Washington Post, 8-31-06
• FDA Warns Consumers Not to Buy or Use Prescription Drugs FDA News, 8-30-06
• Some patients back on Celebrex USA Today, 8-30-06
• Assembly approves universal health care Sacramento Bee, 8-29-06
• Biotech's bright hope: Scientists are newly optimistic that gene therapy will help fight the most serious diseases Los Angeles Times, 8-28-06
• Group raps FDA panels as 'rubber stamps' Bloomberg News, 8-28-06
• Discount Drug Deal Reached: Schwarzenegger, Democrats agree on plan to compel manufacturers to cut costs of medicines for lower–income residents Los Angeles Times, 8-23-06
• Medicare Sees No Increase in Premium for Drugs The New York Times, 8-16-06
• Options Are Available for Seniors In Medi-Gap The Star-Ledger, 8-14-06
• TV Ads for Prescription Drugs Fuel Further Debate Lexington-Herald Leader, 8-10-06
• Health Care Taps “Mystery Shoppers” Wall Street Journal, 8-8-06
• Administration Aims to Set Health–Care Standards Washington Post, 8-7-06
• Medicare Drug Plan is Prescribing Profits, Business Gains Could Diminish As Program Evolves The San Francisco Chronicle, 8-4-06
• Scaling Back Changes to Medicare Payments The New York Times, 8-3-06
• Supe Gives Final OK to Health Care Coverage The San Francisco Chronicle, 7-26-06
• A Windfall From Shifts to Medicare The New York Times, 7-18-06
• With Legislation in Limbo, CMS Launches HSA Demo The Hill, 7-13-06
• Medicare Part D Spending Projections Down Again, Part A and Part B Increases Highlight Need for Further Reforms Centers for Medicare and Medicaid Services, 7-11-06
• Doctors Group Declares War on Drug Ads Orange County Register, 7-6-06
• Drug Prices Up Sharply This Year The New York Times, 6-22-06
• How a Hospital Stumbled Across an Rx for Medicaid Wall Street Journal, 6-22-06
• Big Buyers Push for Steep Cuts from Drug Makers Wall Street Journal, 6-22-06
• Going from the lab to Limbo: The FDA has been delaying decisions on applications, and drugmakers are fuming Business Week, 6-12-06
• FDA Announces New Measures to Protect Americans from Counterfeit Drugs FDA News, 6-9-06
• Watching the watchdog The Boston Globe, 6-8-06
• Latest Drugs Could Shake Up Cancer Market Wall Street Journal, 6-2-06
• FDA clears a generic biotech drug The Boston Globe, 6-1-06
• Study Finds drug benefit caps create unhealthy situation The San Francisco Chronicle, 6-1-06
• Medicare Drug Benefit Viewed as a Work in Progress Knight Ridder, 5-25-06
• Off label, off base? Many Drug Uses Don't Rest on Strong Science Washington Post, 5-23-06
• AIDS Drug Trial Turned Away Washington Post, 5-23-06
• States begin overhaul of health insurance for the poor The San Diego Union-Tribune, 5-23-06
• Small Business Insurance Stalls in Senate Houston Chronicle, 5-11-06
• Orphan, But Not Rare: Pipeline Is Full And Approvals Are Up The Pink Sheet, 5-8-06
• FDA at 100: Six Alumni Take Its Temperature Medical Marketing and Media, 5-1-06
• Putting a Band-Aid on small firms' health costs USA Today, 4-19-06
• Comparison of Schizophrenia Drugs Often Favors Firm Funding Study Washington Post, 4-12-06
• Patients asked to sign vow: No frivolous suits Chicago Sun-Times, 4-12-06
• Most Seniors Enrolled Say Drug Benefit Saves Money Washington Post, 4-12-06
• Pharmaceutical Giants Continue to Raise Prices Higher Than Inflation AARP's Latest Drug Price Study Shows AARP, 4-10-06
• Seniors Flocking To Lower–Cost Generic Drugs In Medicare Part D Medical News Today, 2-9-06
• The Domestic Agenda: On Education and Health, Costly Plans Face Hurdles The New York Times, 2-1-06
• In the Newest War of the States, Forget Red and Blue: These Battle Lines are Forming Over Rapidly Rising Drug Prices The New York Times, 1-31-06
• Enrollment Triples in Plans Offering Health Savings Accounts Los Angeles Times, 1-27-06
• An About Face on Hormone Therapy Wall Street Journal, 1-24-06
• Plaintiff’s paradise waits for latest Vioxx trial The San Francisco Chronicle, 1-23-06
• Alzheimer’s drugs policy reviewed , 1-23-06
• Lawyers May Change Their Tactics in Drug Liability Cases Wall Street Journal, 1-19-06
• FDA Issues New Rules For Drug Labels --- Move Is Designed to Clarify Safety Data For Patients and Physicians Wall Street Journal, 1-19-06
• 'Vioxx like' drugs may still be best option for arthritis write scientists Imperial College, 1-18-06
• Earlier Drug Testing on Humans Okd Los Angeles Times, 1-13-06
• Insurers Offer Consumer-Friendly Health Statements Wall Street Journal, 1-10-06
• Health Care: Can Consumer Choice Cure the Nation's Ills? Wall Street Journal, 1-9-06
• Drug companies will have to pay to get on state list Associated Press Newswires, 1-8-06
• AARP edges away from drug imports The Hill, 1-4-06
• US Pharmaceutical industry limbers up for Medicare’s brave new world: Overhaul of healthcare systems will put drug manufacturers on a collision course with government Financial Times, 1-4-06
• Reaction to new Medicare drug plan mixed Associated Press Newswires, 1-3-06
• Action sought on drug imports: The governor asks Congress to allow purchases from foreign suppliers Sacramento Bee, 1-3-06
• FDA Risk Communication Should Include Drug Benefit Info, PhRMA says The Pink Sheet, 12-19-05
• Health Care for All, Just a (Big) Step Away The New York Times, 12-18-05
• FDA Operation Reveals Many Drugs Promoted as "Canadian" Products Really Originate From Other Countries FDA News, 12-16-05
• Ghost Story: At Medical Journals, Writers Paid by Industry Play Big Role – Articles Appear Under the Name of Academic Researchers, But They Often Get Help Wall Street Journal, 12-13-05
• Florida Legislature Passes Governor’s Managed-Care Medicaid Bill Los Angeles Times, 12-9-05
• U.S. Life Expectancy hits another all-time high, but health officials see trouble spots Associated Press Newswires, 12-8-05
• Lawsuit shield pits unions against vaccine makers The Hill, 12-6-05
• When the doctor is in, but you wish he wasn’t The New York Times, 11-30-05
• Poisonings from a popular pain reliever are on the rise The New York Times, 11-29-05
• Medicaid Cutbacks Divide Democrats Washington Post, 11-28-05
• Valued Lives: Britain Stirs Outcry by Weighing Benefits of Drugs Versus Price: Government Arm Finds Pills for Alzheimer’s Too Costly, Angering Patients, Pfizer Wall Street Journal, 11-22-05
• Problems Cited in Medicare Drug Benefit Sign-Up: On 1st Day, Seniors Report Confusion Over Choices, Frustration With Online Comparison Tool Washington Post, 11-17-05
• Missing Medicine -- Emergency Response: Fearing Avian Flu, Bioterror, U.S. Scrambles to Fill Drug Gap --- Congress Debates Incentives And Liability Protection For Vaccines, Antibiotics --- Trial Lawyers: 'That's Unfair' Wall Street Journal, 11-9-05
• Crucial Antibiotic Rescues Biotech Maker’s Finances The New York Times, 11-9-05
• Feuding Over Vaccines; Doctor’s Vexed by Parent’s Refusal Washington Post, 11-8-05
• Ruling in Merck’s favor was an easy choice for jury The Star-Ledger, 11-6-05
• Bird flu plan targets unknown: Bush maps assault on disease peril that hasn’t yet emerged Chicago Tribune, 11-5-05
• Bush seeking to protect vaccine manufacturers from lawsuits Associated Press Newswires, 11-1-05
• BIO Files Lawsuit Against DC Over Pending Price Control Bill BioWorld Online, 10-31-05
• Trial Lawyers Inc. Health Care:The Lawsuit Industry's Effect on American Health, 2005 Manhattan Institute, 10-26-05
• Drug companies warned on growth – IMS Health Financial Times, 10-26-05
• Report: Rx drug sales to soar in U.S. Associated Press Newswires, 10-25-05
• Warnings on SSRIs, ADHD Drug Should Not Discourage Appropriate Use Medscape, 10-24-05
• Lawmakers push plan to cut Medicaid costs Detroit Free Press, 10-11-05
• WHO: Chronic Diseases May Kill 400 Million by 2015 Associated Press Newswires, 10-5-05
• Getting Your Health Care at Wal-Mart: To Boost Sales, Retail Chains Open In-Store Clinics; A Strep Test and a Bar of Soap Wall Street Journal, 10-5-05
• Program Offers Health Care for Some Part-Time Workers The New York Times, 10-4-05
• Medicare Drug Plan Stumps Seniors USA Today, 10-4-05
• Vermont testing cap on Medicaid Washington Times, 10-3-05
• US FDA to search insurer data for drug safety info Reuters News, 10-3-05
• Report reignites debate over Medicare drug plan The Boston Globe, 9-28-05
• New FDA chief wants to prepare agency to foster transformation in medicine Associated Press Newswires, 9-26-05
• Many Insurers Set to Offer New Medicare Drug Plans The New York Times, 9-24-05
• Experts: Counterfeit drugs becoming major health threat in Europe Associated Press Newswires, 9-22-05
• Council Approves Bill on Suing Drug Companies Over Costs Washington Post, 9-21-05
• Doctors Join to Promote Electronic Record Keeping The New York Times, 9-19-05
• A Victory for Lilly—With Reservations Forbes, 9-19-05
• Medicare's Drug Plan: What to Do Now --- As Key Sign-Up Dates for Benefit Approach, Seniors Face Series of Decisions; Choosing a Policy Wall Street Journal, 9-14-05
• Vioxx trials to pain industry Washington Times, 9-9-05
• FDA Reviews of New Drugs May Signal Tougher Scrutiny Wall Street Journal, 8-23-05
• Germany, a cautionary tale: Price controls cited as one harm to the industry The Philadelphia Inquirer, 8-22-05
• For many, Vioxx verdict may mean more suffering; Lawsuit torrent could deter return to market Chicago Tribune, 8-21-05
• Europe's slow gears pushing scientists away The Philadelphia Inquirer, 8-21-05
• Aftershocks from Vioxx verdict; Legal and financial experts watching the case saw the ruling either as a Texas anomaly or a dire warning to Merck. The Philadelphia Inquirer, 8-20-05
• Vioxx Jurors Sought to Send a Message Associated Press Newswires, 8-19-05
• Access to Prescription Assistance Programs Widened The Hartford Courant, 8-16-05
• Wholesale drug prices top inflation in general, AARP says Associated Press Newswires, 8-16-05
• South Carolina proposing to redefine Medicaid The San Francisco Chronicle, 8-15-05
• Pfizer will change how it markets drugs to public Detroit Free Press, 8-12-05
• The Nation; For Generic Drugs, the Price Is Right in U.S. Plain-label medications can be 78% costlier in Canada, a survey finds. Many Americans are unaware of the savings potential at home. Los Angeles Times, 8-9-05
• Guidelines May Fail to Meet Needs of Elderly Patients With Comorbidities Medscape, 8-9-05
• Radical Surgery For Medicaid? South Carolina Governor Sanford has a plan to slash costs -- but a political battle looms Business Week, 8-8-05
• F.D.A. Responds to Criticism With New Caution The New York Times, 8-6-05
• Medicare to Directly Cover Use Of a Genentech Stroke Drug Wall Street Journal, 8-4-05
• Drug ad controls pledged / Major firms plan to follow new volunteer rules The San Francisco Chronicle, 8-3-05
• Industry Hails Its Medicine Subsidies for Poor; Drug firms 'are getting it,' says a lobbyist, citing their program's aid to about 250,000 -- part of an effort to head off a prescription import bill. Los Angeles Times, 7-27-05
• The Next Phase In Psychiatry --- Largest-Ever Studies on Drugs for Depression, Schizophrenia Could Transform Treatment Wall Street Journal, 7-27-05
• INTERVIEW-WHO will fail to meet AIDS drugs goal Reuters News, 7-26-05
• Inefficient Spending Plagues Medicare; Quality Often Loses Out as 40-Year-Old Program Struggles to Monitor Hospitals, Oversee Payments Washington Post, 7-24-05
• Long-Term-Care Insurance: How Much Is Too Much? The New York Times, 7-24-05
• Report highlights high costs of ignoring health tech Government Health IT, 7-22-05
• U.S. Affirms Support for Vaccines Amid Worries Over Autism Link Wall Street Journal, 7-20-05
• Who's fighting cancer in kids? USA Today, 7-20-05
• 5 Drug-Importing States Add 2 Countries as Sources The New York Times, 7-19-05
• As Medicaid Balloons, Watchdog Force Shrinks The New York Times, 7-19-05
• Ex-shrimper at vanguard of 'personalized medicine' Associated Press Newswires, 7-15-05
• Industry Concerned Drug Watch Will Cause Disruptions, Lawsuits Food & Drug Letter, 7-15-05
• DTC ADVERTISING VALUE STILL A DEBATE AMONG EXPERTS FDA News Drug Daily Bulletin, 7-10-05
• Rival Drug Discount Plans on Fall Ballot in California The New York Times, 7-8-05
• How Safe Are Your Drugs? Not Enough, Some Say Investor's Business Daily, 6-13-05
• Study Links NSAIDS to Increased Risk of Heart Attack Dow Jones Newswires, 6-10-05
• Do these drugs need a warning? The FDA says yes, but doctors who disagree are taking their case to the AMA Chicago Tribune, 6-9-05
• Drug Safety System is Broken, a Top F.D.A. Official Says The New York Times, 6-9-05
• U.S. to Develop Retrieval System for Medical Data Wall Street Journal, 6-6-05
• Some drug prices go up after rivals leave market USA Today, 6-6-05
• Medicare’s Will May Be FDA’s Way Los Angeles Times, 6-5-05
• Follow-up safety testing lags for FDA "fast-track" drugs, study finds The Seattle Times, 6-1-05
• Why Patients Fail to Take Their Medicines Forbes, 5-25-05
• CVS Will Try to Close One Gap Where Counterfeit Drugs Enter Wall Street Journal, 5-25-05
• Crestor has higher incidence of side effects; A new analysis showed that certain important side effects are more common with Crestor than with other cholesterol drugs. But doctors said most users should stay on the drug. SCIENCE & MEDICINE The Miami Herald, 5-24-05
• Insurance Option Has Workers Pay More Los Angeles Times, 5-23-05
• The Informed Patient: Web Grows as Health-Research Tool Wall Street Journal, 5-18-05
• Medicare's chief wants to reward doing right thing The Cleveland Plain Dealer, 5-17-05
• U.S. FDA looking to improve drug safety monitoring. Reuters News, 5-16-05
• US Medicare to help look for drug side effects Reuters News, 5-11-05
• States and Employers Duel Over Health Care The New York Times, 5-6-05
• HSAs More Than Double in Six Months, New AHIP Study Shows America's Health Insurance Plans, 5-5-05
• Autoimmune Diseases: Trying to Shut Off the Body’s Friendly Fire The New York Times, 5-5-05
• The Quest for Custom Cures Boosted by new technology, the burgeoning science of genomics is ushering in an age of personalized medicine. Fortune, 5-2-05
• German Curbs On Drug Costs Rile Big Brands Wall Street Journal, 5-2-05
• Team effort is best medicine for athlete's sight The Star-Ledger, 5-2-05
• Early-Warning Tool for Unsafe Drugs Wall Street Journal, 4-28-05
• New FDA office for drug safety is proposed; Two senators want it to have power to restrict marketing and pull approved drugs if new studies reveal risks. The Philadelphia Inquirer, 4-28-05
• Europe 'lagging further behind US on drugs' Financial Times, 4-28-05
• TV Ads for Drugs Help Boost Prescriptions, Researchers Say Los Angeles Times, 4-27-05
• Number of Uninsured May Be Overstated, Studies Suggest Los Angeles Times, 4-26-05
• A ripple effect for painkillers Los Angeles Times, 4-25-05
• 20 arrested in crackdown on Internet drug pipeline Washington Times, 4-21-05
• When Patients Say: Don't Ban My Drug: Emotional lobbying can keep a treatment on the market despite serious side effects Business Week, 4-20-05
• THE NATION; Former FDA Chief Backs Drug Import Plan; The proposal would protect consumers from substandard and counterfeit medicines, Dr. David Kessler tells a Senate committee. Los Angeles Times, 4-20-05
• Merck to Discount Drugs for Uninsured; Prices to Compare to Canadian Imports Washington Post, 4-20-05
• Are we taking too many drugs? Newsday, 4-19-05
• No headache cure for costly drug regulation: Testing procedures vary greatly between the US, Europe and Japan. Wyeth says the system must be harmonised Financial Times, 4-15-05
• A Bonus for Health, Payable to the Doctor The New York Times, 4-15-05
• Imported Canadian drugs pose security risk, report says. The Globe and Mail, 4-13-05
• New Research Bolsters Tarnished MS Drug - After Withdrawal, Study Highlights Tysabri’s Efficacy Wall Street Journal, 4-13-05
• Patients in pain keep popping pills despite FDA warning. Chicago Tribune, 4-11-05
• Directing the Poor to Free Medicine Wall Street Journal, 4-5-05
• Childbirth for Bargain-Hunters: Pregnant Women Take Lead In Negotiating Over Prices Amid Cutbacks in Coverage Wall Street Journal, 4-5-05
• Smart Drug for Lung Cancer May Be Pulled From Market: Iressa Helps Small Portion of Patients The Boston Globe, 4-5-05
• Doctors Lobbying to Halt Cuts to Medicare Payments The New York Times, 4-4-05
• Is free health care worth a 3-month wait? Ask Canada Chicago Tribune, 4-3-05
• Medicare Puts Data Comparing Hospitals Onto Public Web Site Wall Street Journal, 4-1-05
• MS patients plead for a recalled medication Some doctors agree that Tysabri's dramatic results outweigh risks of a rare, fatal disease contracted by two users Newsday, 3-30-05
• Back from the brink | Millionaire father rescues company; knew drug would help his daughter The San Diego Union-Tribune, 3-25-05
• ACCELR8 ADAPTS TO STRAINS IN MARKET; NEW PRODUCT AIMS TO SAVE LIVES, SLOW ANTIBIOTIC RESISTANCE Rocky Mountain News, 3-21-05
• Eminent Domain Urged As Tool to Cut Drug Costs Washington Post, 3-17-05
• State program debuts to assist with medications | Public linked to discounted, free drugs The San Diego Union-Tribune, 3-17-05
• Drugmakers likely to lob softer pitches Consumer ads come under scrutiny USA Today, 3-16-05
• Doctors seek cure to rash of anti-drug advertising: US medics are worried about 'alarmist' warnings spread by lawyers searching for new clients Financial Times, 3-16-05
• Support for Drug Importation Varies Washington Times, 3-9-05
• The Informed Patient: Doctors' Dilemma: How to Make Patients Stick to Their Regimens Wall Street Journal, 3-9-05
• With Risks of Painkillers Unclear, A Long-Term Study Is Proposed Wall Street Journal, 3-8-05
• Administration considers pay-for-performance for Medicare providers Associated Press Newswires, 3-2-05
• Where Drug's Setback Leaves Patients --- Withdrawal of Tysabri Reshapes Options for Those With Multiple Sclerosis, Crohn's, Severe Arthritis Wall Street Journal, 3-1-05
• Are Too Many Unproven Drugs Receiving FDA Early Approval? Process Comes Under Scrutiny Wall Street Journal, 3-1-05
• A Death Prompts Withdrawal of Promising MS Drug --- Biogen Idec, Elan Recall Tysabri After Users Contract Rare Disorder; Encouraging Words From FDA Wall Street Journal, 3-1-05
• FDA Drug Approval Times Likely to Grow Associated Press Newswires, 2-28-05
• Poll: Most Want U.S. Price Limits on Drugs Associated Press Newswires, 2-24-05
• Medicaid recipients express concern about proposed overhaul Associated Press Newswires, 2-21-05
• Rheumatologists outvote drug-safety specialists Helping patients in pain wins out over increased risks of heart attack, stroke USA Today, 2-21-05
• Drugs Raise Risk of Suicide; Analysis of Data Adds to Concerns On Antidepressants Washington Post, 2-18-05
• FDA Establishes Board to Review Approved Drugs - Steps on Safety Monitoring Follow Concerns Over Vioxx; Critics Question Autonomy Wall Street Journal, 2-16-05
• What Makes a Drug Too Risky? There's No Easy Answer Wall Street Journal, 2-16-05
• Bush to Retain FDA's Acting Chief - Veteran Administrator Would Be Unlikely to Seek Broad Changes at Agency Wall Street Journal, 2-15-05
• Middle-Class Families Strain Public Health-Insurance Plans Wall Street Journal, 2-15-05
• States' Bid for Cheaper Medicine Sputters - Official Web Sites for Buying Drugs From Canada Are Slow to Take Off With Consumers Wall Street Journal, 2-14-05
• Rare Strain of HIV Resists Drugs, Builds Rapidly Into AIDS Wall Street Journal, 2-14-05
• Pharma Prophet: Garret FitzGerald saw the Cox-2 debacle coming. Now he sees the drugs' salvation. Forbes, 2-14-05
• Why U.S., Canada Differ on Safety Of Attention-Deficit Drug Wall Street Journal, 2-11-05
• Health Group offers remedy to businesses; A coalition is moving into South Florida to increase healthcare quality and lower costs for large employers The Miami Herald, 2-8-05
• Novartis Weighs Cap on Prexige Use: Company May Seek Limits On FDA Approval, at First, To Study Effects on Heart Wall Street Journal, 2-7-05
• Internet pharmacies forced to open shop overseas; Concerned about Ottawa crackdown The Globe and Mail, 2-7-05
• NIH Grant Recipients Are 'Asked' to Post Data New Policy on 'Public Access' Draws Criticism Washington Post, 2-4-05
• 10-year goal: Help millions more get health insurance USA Today, 2-4-05
• Arthritis Drug Study in 2000 Found Risks; Results Show Pfizer May Have Known About Celebrex's Heart and Stroke Problems Washington Post, 2-1-05
• List saves much-needed Medicaid money, but some say it's too restrictive Associated Press Newswires, 1-29-05
• Report on Eli Lilly Is Retracted Wall Street Journal, 1-28-05
• Bush Promotes Health Savings Accounts; He Says Plan Would Cut Insurance Costs and Increase Patient Responsibility Washington Post, 1-27-05
• The Informed Patient: Are Treatment Guidelines Reliable? Wall Street Journal, 1-26-05
• Study by Vioxx Critic Links Drug to Extra Coronary Cases Wall Street Journal, 1-25-05
• Few seniors use Web for health info; Many of those 65 and older are missing out on discounts and online resources, a study finds. Los Angeles Times, 1-24-05
• New Medicare Drug Rules Balance Access and Costs The New York Times, 1-22-05
• Pfizer Delays Cox-2 Polyp Drug Amid Safety Review in Europe Wall Street Journal, 1-21-05
• Gene-Based Drug Research Takes Shape at Novartis Wall Street Journal, 1-19-05
• Wyeth Nears Diet-Drug Settlement: Company Sets Framework With Plaintiffs' Lawyers For Most Remaining Cases Wall Street Journal, 1-18-05
• No Pain, Some Gain: New drugs aimed at specific neuron targets promise relief from chronic agony Business Week, 1-17-05
• Eli Lilly Goes On the Offensive to Defend Prozac Wall Street Journal, 1-13-05
• Savings Uncertain In Import Drug Plan: Questions Raised In Montgomery Washington Post, 1-13-05
• Drug makers offer discount prescription card - TogetherRxAccess would give breaks of up to 40 percent to America's medically uninsured The Star-Ledger, 1-12-05
• Painkillers: The Misadventure Continues Washington Post, 1-11-05
• Health Savings Accounts Off to Slow Start The New York Times, 1-11-05
• Americans Save Less Buying Canadian Drugs Wall Street Journal, 1-5-05
• Malpractice Bill Shields Drugmakers Washington Post, 1-5-05
• The Nation; Medicare to Screen for Alcoholism; The coverage is part of a move toward prevention of several costly conditions that some say is overdue. Participation could be the big hurdle. Los Angeles Times, 1-2-05
• Second Opinion: As Drug-Safety Worries Grow, Looking Overseas for Solutions - French Vigilance Centers Spot Problems, and U.K. Traces Issues With 'Green Cards' - A High-Tech Prescription Pad Wall Street Journal, 12-31-04
• Doctors, Too, Ask: Is This Drug Right? The New York Times, 12-30-04
• Studies on Painkillers In Jeopardy; Researchers Assess Risk-Benefit Ratio Washington Post, 12-26-04
• Painkillers Fall Under Sharp Review --- Health Officials to Focus On Side Effects, With Eye Toward Regulatory Action Wall Street Journal, 12-24-04
• Good Pill, Bad Pill: Science Makes it Hard to Decipher The New York Times, 12-22-04
• Rethinking Over-the-Counter Drugs --- Finding on Aleve Underscores Dearth of Overall Research; Little Incentive for Trials Wall Street Journal, 12-22-04
• Heart Risk Seen in Naproxen Wall Street Journal, 12-21-04
• Patients Weigh Pain vs. Risk : Some Former Vioxx Takers Say Alternatives Fall Short Or Carry Other Dangers Wall Street Journal, 12-21-04
• Celebrex warning echoes safety failures; An analysis shows that, as the number of new drugs like Celebrex -- now linked to heart attack risks -- being given first to Americans has increased, reports of drug-induced ailments have grown. The Miami Herald, 12-18-04
• Drug industry falling short in research and development / ANALYSIS: Firms are paying the price for faulty science Houston Chronicle, 12-18-04
• Making Vaccines Good Business The New York Times, 12-12-04
• Report warns of drug price controls Washington Times, 12-8-04
• Celebrex Less Risky Than Vioxx Wall Street Journal, 12-7-04
• Importing of drugs approved by AMA; Support increases pressure on FDA Chicago Tribune, 12-7-04
• NIH licensing performance under par Nature, 12-7-04
• Americans Relying More on Prescription Drugs, Report Says The New York Times, 12-3-04
• U.S. drug safety system shaky, experts say; Recently, troubling news about several high-profile drugs has sapped confidence in the system charged with exposing dangerous medicines. The Miami Herald, 12-2-04
• No Relief Seen In the Growth Of Employers' Health Costs The New York Times, 12-2-04
• Many See Hope in Parkinson's Drug Pulled From Testing The New York Times, 11-26-04
• FDA Sets Its Priorities for Drug Safety Debate in Next Congress Food & Drug Letter, 11-24-04
• Drug Companies Look to China For Cheap R&D Wall Street Journal, 11-22-04
• Mouse Study Hints at Effects of Cox-2 Inhibitors on Heart Wall Street Journal, 11-19-04
• Reuters Summit-AstraZeneca CEO urges US to spur drug innovation. Reuters News, 11-17-04
• Preparing for Vioxx Suits, Both Sides Seek Friendly Venues Wall Street Journal, 11-17-04
• Tiny Antennas To Keep Tabs On U.S. Drugs The New York Times, 11-15-04
• NEWS AND ANALYSIS: Do New Drugs Always Have to Cost So Much? The New York Times, 11-14-04
• Dosanjh threatens to cut off Web drugs The Globe and Mail, 11-11-04
• Pfizer chief urges new consensus on healthcare. Financial Times, 11-11-04
• Firm offers discounted generic medicine to low-income families The Cleveland Plain Dealer, 11-10-04
• Merck Faces U.S. Criminal Probe Over Vioxx Drug Wall Street Journal, 11-9-04
• Medicare faces cost crisis; Multitrillion-dollar deficits loom over federal programs The San Francisco Chronicle, 11-7-04
• F.D.A.'s Drug Safety System Will Get Outside Review The New York Times, 11-6-04
• Vulnerable System -- Behind Flu-Vaccine Shortage: Struggle to Police Drugs Globally -- Chiron Case Shows Failure Of Agencies to Swap Data; A Bad News Wake-Up Call -- Rising Overseas Duty for FDA Wall Street Journal, 11-5-04
• Lawyers Organizing for Mass Suits Over Vioxx The New York Times, 11-5-04
• Medicare Tweaks Preventive Plans Wall Street Journal, 11-4-04
• $18B tab possible in recall of Vioxx: Study says Merck could face more than 50,000 lawsuits NJ.com, 11-4-04
• Medicare Takes Steps Broadening Coverage of Cancer Care The New York Times, 11-2-04
• How Bad Will the Lawsuits Get? Really, really bad. Forbes, 11-1-04
• Is Kaiser The Future Of American Health Care? The New York Times, 10-31-04
• U.S. drug prices 81% higher than in 7 Western nations Study of name brands shows steep rise in differential since 2000 The San Francisco Chronicle, 10-29-04
• Vaccine Useful Against Cancer In Clinical Trial The New York Times, 10-29-04
• Ancestry Trumps Race In Predicting Efficacy Of Drug Treatments Wall Street Journal, 10-29-04
• A New Way to Save on Premiums Kiplinger's Personal Finance, 10-28-04
• The Latest Birth-Control Battle: Having Won Coverage for the Pill, Employees Now Press for Insurance to Pay for Newer Alternatives Wall Street Journal, 10-26-04
• Vioxx ads topped $500M Drug maker Merck spent heavily against rival Pfizer The Star-Ledger, 10-24-04
• The Informed Patient: Does Disease Management Pay Off? Wall Street Journal, 10-20-04
• Buying Health Insurance, Cafeteria Style – Some Employers Offer a Menu of Deductibles, Co-Payments, Networks and Prescription Plans Wall Street Journal, 10-19-04
• US’ Snow Says Rest of World Should Pay More for Drugs Reuters News, 10-19-04
• Taking Aim at Ads for the Purple Pill The New York Times, 10-19-04
• Canadian Groups Seek Ban on Cross-Border Drug Shopping Associated Press Newswires, 10-19-04
• "Off-Label" - And Out Of Bounds? When drugmakers promote products for unproven uses, they may be courting trouble Business Week, 10-18-04
• A.M.A. Says Government Should Negotiate on Drugs The New York Times, 10-17-04
• Importing Less Expensive Drugs Not Seen as Cure for U.S. Woes The New York Times, 10-16-04
• Selling Prescription Drugs to the Consumer The New York Times, 10-12-04
• Health Costs - Decisions, Decisions: Health Savings Account Give Consumers More Incentive to Manage Their Health Care and Costs; But Will They Have the Knowledge? Wall Street Journal, 10-11-04
• Flu Shortage Shows System Flaws; Fewer Companies Making Vaccines The Boston Globe, 10-10-04
• Shortage Was Predicted The New York Times, 10-7-04
• Task Force: Americans Don’t Have to Look North to Find Cheap Prescription Drugs Associated Press Newswires, 10-6-04
• Putting Side Effects in Perspective – Despite Vioxx Withdrawal, The Benefits of Medicines Can Outweigh the Risks Wall Street Journal, 10-5-04
• Vioxx Lawsuits May Focus on FDA Warning in 2001 Wall Street Journal, 10-5-04
• Vioxx Recall May Bring Flood of Suits to Merck The New York Times, 10-5-04
• Evaluating Vioxx Alternatives Wall Street Journal, 10-5-04
• Vioxx Recall Raises Questions on FDA's Safety Monitoring Wall Street Journal, 10-4-04
• Promise and Peril of Vioxx Cast Harsher Light on New Drugs Washington Post, 10-3-04
• Coping Without Vioxx – Recall of Merck’s Pain Drug Sparks Hunt for Alternatives; Just How Safe is Celebrex? Wall Street Journal, 10-1-04
• Vioxx's Removal May Not Affect Care Much; Other Drugs Can Be Used, Experts Say Washington Post, 10-1-04
• Health and Money Issues Arise Over Who Pays for Weight Loss The New York Times, 9-30-04
• FDA Says Intercepted Canadian Drugs Unsafe Associated Press Newswires, 9-30-04
• Kucinich Wants Government to Oversee Drug Research The Cleveland Plain Dealer, 9-29-04
• What is a health savings account and what are its benefits? Associated Press Newswires, 9-29-04
• U.S. drug agency alleges intercepted Canadian prescription drugs unsafe, made elsewhere Associated Press Newswires, 9-28-04
• Dr. McClellan's Medicare Rx - Deft Political Hand Reshapes Health-Insurance Behemoth Wall Street Journal, 9-28-04
• FDA Will Warn on Antidepressants: Labels Will Say the Drugs Increase Youth Suicide Risk; 'Black Box' Alert Considered Wall Street Journal, 9-24-04
• Insider Challenges Drug Industry on Imports The New York Times, 9-24-04
• When the Insured Struggle to Pay for Health Care Wall Street Journal, 9-23-04
• Critics: Legalization Will Lead To Job Losses The Boston Globe, 9-23-04
• Low-Income Nonapplicants to Get Medicare Drug Cards The New York Times, 9-23-04
• So much for tripping the life fantastic; The increase in rates of arthritis and the lengthening of surgical wait times makes it harder for many people to stay active The Globe and Mail, 9-22-04
• The Informed Patient: Electronic Medical Records Are Taking Root Locally Wall Street Journal, 9-22-04
• Fight to Legalize Drug Imports Has Unlikely Ally -- Pfizer Executive Will Join Washington Lawmakers In a High-Visibility Event Wall Street Journal, 9-22-04
• MEDICINE; Patients who cut corners on drugs don't tell doctors; Rising costs are forcing many to reduce doses or skip them entirely. Physicians don't bring up the issue; often, neither do patients. Los Angeles Times, 9-20-04
• Scared parents keep young out of antidepressant trial Washington Times, 9-20-04
• Rush for Medical Scans Raises Concerns on Cost The Boston Globe, 9-18-04
• Medicare Web Site Points Out Less Costly Drugs Wall Street Journal, 9-16-04
• Antidepressants Urged to Have Stern Warnings: FDA Panel Recommends Forcing Drug Makers to Cite Risk of Suicidal Tendency for Youth Wall Street Journal, 9-15-04
• Canada Looks for Ways to Fix Its Health Care System The New York Times, 9-12-04
• Few Enroll in Low-Cost Drug Demonstration The New York Times, 9-11-04
• Health Insurance Costs Keep Rising Premiums for Employer-Sponsored Plans Grew by 11.2%, Survey Finds Washington Post, 9-10-04
• Medigap Premiums Vary Greatly Among Insurers: Retirees Pay Thousands of Dollars More Each Year Than Needed for Coverage Wall Street Journal, 9-8-04
• HMO To Unveil Plan For Elderly Poor; Colorado Access To Key On Increased Medicare Payments Rocky Mountain News, 9-1-04
• Canadian sites look overseas for drug supply; To combat shortages, online pharmacies used by U.S. consumers are seeking new sources. Safety could be an issue. Los Angeles Times, 8-30-04
• Drug Makers Sued on Pricing; Fourteen pharmacies accuse the companies of charging more for medicines in the U.S. Los Angeles Times, 8-27-04
• Record Level of Americans Not Insured on Health The New York Times, 8-27-04
• 15 Illnesses Drive Up Costs Conditions Linked to 56% of Increase in Health Care Bills Washington Post, 8-25-04
• Bookshelf: Fighting Disease Is Only Half the Battle Wall Street Journal, 8-25-04
• Discounted drugs urged for uninsured Californians; Official rejects Canadian medications as illegal The San Diego Union-Tribune, 8-20-04
• Medicare Proposal May Aid Insurers - Preliminary List of Drugs For New Benefits Could Be A Blow to Manufacturers Wall Street Journal, 8-19-04
• Irish officials: prescription drug import plan "unusual" Associated Press Newswires, 8-19-04
• EUROPE'S gag reflex - Drug companies in Europe fight to take their message to the masses The Star-Ledger, 8-18-04
• RESPONSE TO SOARING COSTS: Prescription battle Lawmakers in West Virginia prepare to push for price controls placed on drugs as powerful pharmaceutical industry tries to defeat effort Newsday, 8-16-04
• State prescription drug buying club not taking off as planned Associated Press Newswires, 8-15-04
• THE COLOR OF MONEY: Web Pharmacies Can Endanger Your Health and Wallet Washington Post, 8-12-04
• Canadian pharmacies fill U.S. orders overseas Star Tribune, 8-12-04
• UA officials discussing proposed drug institute Associated Press Newswires, 8-11-04
• Medicare Drug Benefit Fails to Boost Bush, Survey Finds Washington Post, 8-11-04
• LIABILITY LAWSUITS Can FDA seal be broken? A fight is raging on whether agency’s approval of medical devices or drugs can prevent litigation Newsday, 8-11-04
• Health Plan That Cuts Costs Raises Doctors’ Ire The New York Times, 8-11-04
• Fake-Drug Sites Keep a Step Ahead - One Is Busted for Selling Bogus Pharmaceuticals; New Vendor Grabs Address Wall Street Journal, 8-10-04
• Encore (A Special Report): HealthMiracle Cure? Medicare is bringing “disease management” to your door; Here’s what you need to know Wall Street Journal, 8-9-04
• Price of AIDS Drug Allowed to Stand - NIH Won’t Force Abbott To Reduce Cost of Norvir, Developed With Tax Dollars Wall Street Journal, 8-5-04
• Heralded Heart Drug Has Unexpected Risks - Hospitalizations, Deaths Highlight Hazards Of Applying Study Results to Individual Patients Wall Street Journal, 8-5-04
• Canada feels squeeze from drug makers; Major drug manufacturers have significantly cut back their supplies to Canadian pharmacies, hoping to curtail purchases by Americans in search of cheaper prescription medications. The Miami Herald, 8-4-04
• Lilly Plans Broad Access to Results on Its Drug Trials Wall Street Journal, 8-3-04
• Checking Up on Hospitals: New Web Site Rates Facilities' Performance in Heart, Pregnancy, Pneumonia Care Washington Post, 8-3-04
• Biotech Unsure On Kerry The Boston Globe, 7-31-04
• Medicare discount cards living up to their hype; A study found that Medicare drug discount cards deliver on promised savings, but confusion is keeping enrollment down. The Miami Herald, 7-29-04
• IRS issues final rules for HSAs Galen Institute, 7-27-04
• Postmarketing Studies Becoming Essential to New Drug Development in the U.S. Tufts Center for the Study of Drug Development, 7-26-04
• In a Shift, Bush Moves to Block Medical Suits The New York Times, 7-25-04
• US drug imports rising despite warnings, FDA says. Reuters News, 7-24-04
• US FDA to revise drug review letters Reuters News, 7-19-04
• Bush Administration Seeks to Clear Confusion About Medicare Cards Wall Street Journal, 7-19-04
• Alzheimer's Association, National Institute on Aging Seek to Expedite Prevention Trials for Alzheimer's News Release, 7-18-04
• Next to the Express Checkout, Express Medical Care The New York Times, 7-18-04
• Offshore firms selling diluted, fake drugs as Canadian; FDA warns in battle over cheap imports The Globe and Mail, 7-15-04
• Massachusetts Lawmakers Approve Constitutionally Protected-Health Care Associated Press Newswires, 7-14-04
• Pressure Points: Attacking Rise in Health Costs, Big Company Meets Resistance: Pitney Bowes Finds Culprits, But Can't Beat Them All; $11,447 Knee Arthroscopy; Marketplace 'Wasn't Working' Wall Street Journal, 7-13-04
• Trade Agreement May Undercut Importing of Inexpensive Drugs The New York Times, 7-12-04
• Seniors' Prescription Drug Costs: Rx for hope and frustration; Canada offers big savings, but U.S. reimportation bill stalls Detroit Free Press, 7-10-04
• Pfizer to Offer Deep Discounts On Drugs for Uninsured People Wall Street Journal, 7-8-04
• Fitter workers may help trim costs for firms The Dallas Morning News, 7-7-04
• Drug Cards: Who Will Win The Pot? Seniors are flummoxed - but insurers and distributors see a ripe opportunity Business Week, 7-5-04
• Price controls predicted for Medicare drugs The Philadelphia Inquirer, 7-5-04
• Cost of prescriptions does affect health Financial Times, 6-25-04
• New Way to Curb Medical Costs: Make Employees Feel the Sting Wall Street Journal, 6-23-04
• A credit card is enough for some online U.S. pharmacies; GAO investigators bought the generic version of Vicodin without a prescription on eight Web sites. The Philadelphia Inquirer, 6-18-04
• GAO Uncovers Flaws In Online Drug Sales Washington Post, 6-17-04
• Increasing co-pays could ultimately cost employers Los Angeles Times, 6-17-04
• Pharmacists Offer Drug-Discount Card as Rival to PBMs' Wall Street Journal, 6-16-04
• Novartis, Pfizer Drugs Found Equal in Cutting Cardiac Deaths Wall Street Journal, 6-15-04
• Matched Sets? Washington Post, 6-15-04
• Big Employers Join Forces in Effort to Negotiate Lower Drug Prices The New York Times, 6-12-04
• A Prescription For Healthcare: Professor: Get Industry To Compete Over Quality Instead Of Shifting Costs The Boston Globe, 6-8-04
• Comparing Costs: Push for online drug prices Newsday, 6-1-04
• Drug execs say Europe price falls hurt investment Reuters News, 5-27-04
• State ready to tighten rules on drug wholesalers: Effort follows surge in fake medicines The Star-Ledger, 5-27-04
• Increases in Health Care Premiums Are Slowing The New York Times, 5-27-04
• Internet drug sales to Americans may soon become Canada's pain; A task force is studying whether on-line retailing will cause shortages of prescription medicines here The Globe and Mail, 5-26-04
• As drug co-pays rise, health may decline Los Angeles Times, 5-24-04
• Shifting Drug Prices Muddy Medicare Card Choice Washington Post, 5-21-04
• State pharmacists fight back against imported drugs with own Web site Associated Press Newswires, 5-20-04
• US Closer to battle with Europe over drug prices Financial Times, 5-15-04
• House Panel Scolds NIH Chief, HHS Members Threaten To Pursue New Ethics Legislation Washington Post, 5-13-04
• Companies Join to Offer Health Care to Part-Time Employees The New York Times, 5-13-04
• Only in America A German Raised on Universal Health Care Learns About U.S. Care the Hard Way Washington Post, 5-11-04
• Call for Medicare to Negotiate: Missed drug bargains? Some say government should extract lower prices from firms, just as veterans agency does, but opponents say free-market approach is best Washington Bureau, 5-10-04
• A Radical Prescription: While most companies look to slash health costs by shifting more expenses to employees, Pitney Bowes took a different tack; The results were surprising Wall Street Journal, 5-10-04
• Mood Disorder: In Debate Over Antidepressants, FDA Weighed Risk of False Alarm - Doubting Data on Suicide And Kids, Officials Stopped Presentation Wall Street Journal, 5-2-04
• Hospital Bills Top Health Care Tabs Washington Times, 0-0-00